P-594 Extended survival in stage IV patients treated with low dose maintained chemotherapy (Englisch)
- Neue Suche nach: Yamaguchi, N.
- Neue Suche nach: Rangel-Pestana, D.
- Neue Suche nach: Vargas, F.
- Neue Suche nach: Araujo, M.
- Neue Suche nach: Donatangelo, S.
- Neue Suche nach: Marini, A.
- Neue Suche nach: Naves, A.
- Neue Suche nach: Souza, A.
- Neue Suche nach: Cordeiro, I.
- Neue Suche nach: Bevilacqua, R.
- Neue Suche nach: Yamaguchi, N.
- Neue Suche nach: Rangel-Pestana, D.
- Neue Suche nach: Vargas, F.
- Neue Suche nach: Araujo, M.
- Neue Suche nach: Donatangelo, S.
- Neue Suche nach: Marini, A.
- Neue Suche nach: Naves, A.
- Neue Suche nach: Souza, A.
- Neue Suche nach: Cordeiro, I.
- Neue Suche nach: Bevilacqua, R.
In:
LUNG CANCER -AMSTERDAM-
;
49
;
S274-S275
;
2005
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P-594 Extended survival in stage IV patients treated with low dose maintained chemotherapy
-
Beteiligte:Yamaguchi, N. ( Autor:in ) / Rangel-Pestana, D. ( Autor:in ) / Vargas, F. ( Autor:in ) / Araujo, M. ( Autor:in ) / Donatangelo, S. ( Autor:in ) / Marini, A. ( Autor:in ) / Naves, A. ( Autor:in ) / Souza, A. ( Autor:in ) / Cordeiro, I. ( Autor:in ) / Bevilacqua, R. ( Autor:in )
-
Erschienen in:LUNG CANCER -AMSTERDAM- ; 49 ; S274-S275
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2005
-
Format / Umfang:S274-S275
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99424
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99424 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 49
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Bremnes, R. M. / Sirera, R. / Camps, C. et al. | 2005
- 13
-
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literatureBerghmans, T. / Paesmans, M. / Meert, A. P. / Mascaux, C. / Lothaire, P. / Lafitte, J. J. / Sculier, J. P. et al. | 2005
- 25
-
Complete resection in lung cancer surgery: proposed definitionRami-Porta, R. / Wittekind, C. / Goldstraw, P. et al. | 2005
- 35
-
NNK-induced hamster lung adenocarcinomas over-express b2-adrenergic and EGFR signaling pathwaysSchuller, H. M. / Cekanova, M. et al. | 2005
- 47
-
Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer-in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenaseInoue, K. / Takao, M. / Watanabe, F. / Tarukawa, T. / Shimamoto, A. / Kaneda, M. / Sakai, T. / Fukushima, M. / Shimpo, H. / Yada, I. et al. | 2005
- 55
-
Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significanceUramoto, H. / Sugio, K. / Oyama, T. / Nakata, S. / Ono, K. / Yoshimastu, T. / Morita, M. / Yasumoto, K. et al. | 2005
- 63
-
Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer-a multicenter studyKawai, H. / Tada, A. / Kawahara, M. / Nakai, K. / Maeda, H. / Saitou, R. / Iwami, F. / Ishikawa, K. / Fukai, S. / Komatsu, H. et al. | 2005
- 71
-
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Gorn, M. / Anige, M. / Burkholder, I. / Muller, B. / Scheffler, A. / Edler, L. / Boeters, I. / Panse, J. / Schuch, G. / Hossfeld, D. K. et al. | 2005
- 77
-
Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients?Jatoi, A. / Williams, B. / Nichols, F. / Marks, R. / Aubry, M. C. / Wampfler, J. / Finke, E. E. / Yang, P. et al. | 2005
- 85
-
Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancerImaizumi, M. / Chubu, J. et al. | 2005
- 95
-
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureManus, M. P. / Hicks, R. J. / Matthews, J. P. / Wirth, A. / Rischin, D. / Ball, D. L. et al. | 2005
- 109
-
Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?Carolan, H. / Sun, A. Y. / Bezjak, A. / Yi, Q. L. / Payne, D. / Kane, G. / Waldron, J. / Leighl, N. / Feld, R. / Burkes, R. et al. | 2005
- 117
-
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities-a multicenter phase II trialHirsh, V. / Latreille, J. / Kreisman, H. / Desjardins, P. / Ofiara, L. / Whittom, R. / Fox, S. / Palayew, M. D. / Pintos, J. et al. | 2005
- 125
-
Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reportsKitazaki, T. / Fukuda, M. / Soda, H. / Kohno, S. et al. | 2005
- 129
-
Multivariate analysis of factors predictive of brain metastases in localised non-small call lung carcinomaKilickap, S. / Aksoy, S. / Erman, M. et al. | 2005
- 131
-
Reply to "Multivariate analysis of factors predictive of brain metastases in localized non-small lung carcinoma" Dr. Kilickap et al.Westeel, V. et al. | 2005
- 133
-
Do we need a size-based subclassification for lung cancers larger than 3cm?Pramesh, C. S. / Mistry, R. C. / Agarwal, J. et al. | 2005
- 135
-
Reply to Dr. PrameshCangir, A. K. et al. | 2005
- 137
-
Smoking status and adenocarcinoma histology may explain an improved survival in the female non-small cell lung cancer patientsAltundag, K. / Altundag, O. / Morandi, P. / Gunduz, M. et al. | 2005
- 141
-
Instruction to authors| 2005
- 145
-
Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinomaBartling, B. / Hofmann, H. S. / Boettger, T. / Hansen, G. / Burdach, S. / Silber, R. E. / Simm, A. et al. | 2005
- 155
-
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinomaWang, Y. / Fang, S. / Wei, L. / Wang, R. / Jin, X. / Wen, D. / Li, Y. / Guo, W. / Wang, N. / Zhang, J. et al. | 2005
- 163
-
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancerMortenson, M. M. / Schlieman, M. G. / Virudachalam, S. / Lara, P. N. / Gandara, D. G. / Davies, A. M. / Bold, R. J. et al. | 2005
- 171
-
Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancerGasinska, A. / Kolodziejski, L. / Niemiec, J. / Dyczek, S. et al. | 2005
- 181
-
Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosisWisnivesky, J. P. / Henschke, C. / McGinn, T. / Iannuzzi, M. C. et al. | 2005
- 187
-
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypiaKennedy, T. C. / Franklin, W. A. / Prindiville, S. A. / Cook, R. / Dempsey, E. C. / Keith, R. L. / Hirsch, F. R. / Merrick, T. A. / Shroyer, K. R. / Petty, T. L. et al. | 2005
- 193
-
Do elderly people with lung cancer benefit from palliative radiotherapy?Turner, N. J. / Muers, M. F. / Haward, R. A. / Mulley, G. P. et al. | 2005
- 203
-
Adrenalectomy for solitary adrenal metastases from non-small cell lung cancerPfannschmidt, J. / Schlolaut, B. / Muley, T. / Hoffmann, H. / Dienemann, H. et al. | 2005
- 209
-
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: Contemporary experience from a single institutionGiordano, K. F. / Jatoi, A. / Adjei, A. A. / Creagan, E. T. / Croghan, G. / Frytak, S. / Jett, J. R. / Marks, R. / Molina, J. / Okuno, S. et al. | 2005
- 217
-
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapyYamazaki, S. / Sekine, I. / Matsuno, Y. / Takei, H. / Yamamoto, N. / Kunitoh, H. / Ohe, Y. / Tamura, T. / Kodama, T. / Asamura, H. et al. | 2005
- 225
-
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North AmericaHo, C. / Murray, N. / Laskin, J. / Melosky, B. / Anderson, H. / Bebb, G. et al. | 2005
- 233
-
Randomized study of vinorelbine-gemcitabine versus vinorelbine-carboplatin in patients with advanced non-small cell lung cancerTan, E. H. / Szczesna, A. / Krzakowski, M. / Macha, H. N. / Gatzemeier, U. / Mattson, K. / Wernli, M. / Reiterer, P. / Hui, R. / Pawel, J. V. et al. | 2005
- 241
-
Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II studyRapti, A. / Agelidou, A. / Stergiou, I. / Agelidou, M. / Nikolakopoulos, I. / Varthalitis, J. / Kalykaki, A. / Chainis, K. / Tzanakis, N. / Georgoulias, V. et al. | 2005
- 245
-
Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapyNishio, M. / Matsuda, M. / Ohyanagi, F. / Sato, Y. / Okumura, S. / Tabata, D. / Morikawa, A. / Nakagawa, K. / Horai, T. et al. | 2005
- 253
-
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancerQuoix, E. / Breton, J. L. / Gervais, R. / Wilson, J. / Schramel, F. / Cardenal, F. / Ross, G. / Preston, A. / Lymboura, M. / Mattson, K. et al. | 2005
- 263
-
Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology GroupKudoh, S. / Nakamura, S. / Nakano, T. / Komuta, K. / Isobe, T. / Katakami, N. / Fukuda, Y. / Takada, Y. / Takada, M. / Fukuoka, M. et al. | 2005
- 271
-
Large cell carcinoma of the lung mimicking a germ cell tumor: The potential value of chromosome analysisAhmed, S. M. / Cramer, H. / Ulbright, T. M. / Vance, G. H. / Hanna, N. et al. | 2005
- 275
-
Is the pTNM really pathological?Kuzdzal, J. / Zielinski, M. et al. | 2005
- 277
-
Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancerHotta, K. / Matsuo, K. / Ueoka, H. et al. | 2005
- 279
-
HER2/neu intragenic kinase domain mutations may be major determinant of response to trastuzumab or specific kinase inhibitors in non-small cell lung cancer patientsAltundag, O. / Altundag, K. / Ozcakar, B. / Silay, Y. S. et al. | 2005
- 281
-
9th Central European Lung Cancer Conference in GdanskSkrzypski, M. / Szymanowska, A. et al. | 2005
- 285
-
Lung Cancer-An updateHansen, H. H. et al. | 2005
- 289
-
Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: A systematic review of phase III trialsBarlesi, F. / Pujol, J. L. et al. | 2005
- 299
-
Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, ChinaShen, M. / Rothman, N. / Berndt, S. I. / He, X. / Yeager, M. / Welch, R. / Chanock, S. / Caporaso, N. / Lan, Q. et al. | 2005
- 311
-
Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancerRazmkhah, M. / Doroudchi, M. / Ghayumi, S. M. / Erfani, N. / Ghaderi, A. et al. | 2005
- 317
-
Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, ChinaLan, Q. / Shen, M. / Berndt, S. I. / Bonner, M. R. / He, X. / Yeager, M. / Welch, R. / Keohavong, P. / Donahue, M. / Hainaut, P. et al. | 2005
- 325
-
Expression of HIF-1a, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancerKim, S. J. / Rabbani, Z. N. / Dewhirst, M. W. / Vujaskovic, Z. / Vollmer, R. T. / Schreiber, E. G. / Oosterwijk, E. / Kelley, M. J. et al. | 2005
- 337
-
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cellsKitazaki, T. / Oka, M. / Nakamura, Y. / Tsurutani, J. / Doi, S. / Yasunaga, M. / Takemura, M. / Yabuuchi, H. / Soda, H. / Kohno, S. et al. | 2005
- 345
-
The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cellsOguri, T. / Achiwa, H. / Bessho, Y. / Muramatsu, H. / Maeda, H. / Niimi, T. / Sato, S. / Ueda, R. et al. | 2005
- 353
-
Differential expression of survivin-2B and survivin-DEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)Ling, X. / Yang, J. / Tan, D. / Ramnath, N. / Younis, T. / Bundy, B. N. / Slocum, H. K. / Yang, L. / Zhou, M. / Li, F. et al. | 2005
- 363
-
cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancerSeve, P. / Mackey, J. R. / Isaac, S. / Tredan, O. / Souquet, P. J. / Perol, M. / Cass, C. / Dumontet, C. et al. | 2005
- 371
-
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancersBerardi, R. / Brunelli, A. / Tamburrano, T. / Verdecchia, L. / Onofri, A. / Zuccatosta, L. / Gasparini, S. / Santinelli, A. / Scartozzi, M. / Valeri, G. et al. | 2005
- 377
-
Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: Preliminary results from a randomised clinical trialLarsen, S. S. / Vilmann, P. / Krasnik, M. / Dirksen, A. / Clementsen, P. / Maltbaek, N. / Lassen, U. / Skov, B. G. / Jacobsen, G. K. et al. | 2005
- 387
-
Optical coherence tomography in the diagnosis of bronchial lesionsTsuboi, M. / Hayashi, A. / Ikeda, N. / Honda, H. / Kato, Y. / Ichinose, S. / Kato, H. et al. | 2005
- 395
-
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancerStephens, R. J. / Girling, D. J. / Hopwood, P. / Thatcher, N. et al. | 2005
- 401
-
A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancerClarke, S. J. / Boyer, M. J. / Millward, M. / Underhill, C. / Moylan, E. / Yip, D. / White, S. / Childs, A. / Beale, P. / Latz, J. et al. | 2005
- 413
-
EGFR mutations in malignant pleural effusion of non-small cell lung cancer: A case reportHuang, M. J. / Lim, K. H. / Tzen, C. Y. / Hsu, H. S. / Yen, Y. / Huang, B. S. et al. | 2005
- 417
-
Gefitinib in patients with non-small cell lung cancer: Symptomatic improvement within a few daysBearz, A. / Vaccher, E. / Spazzapan, S. / Berretta, M. / Tirelli, U. et al. | 2005
- 419
-
Int7G24A variant of the TGFBR1 gene and cancer risk: A meta-analysis of three case-control studiesZhang, H. T. et al. | 2005
- 421
-
Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancerOral, E. N. et al. | 2005
- 423
-
Is postoperative chemotherapy and/or postoperative radiotherapy in stage IIIA non-small cell lung cancer feasible?Beckendorf, V. / Spaeth, D. et al. | 2005
- 425
-
Comment on "The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer" by A.E. Martin-Ucar, D.A. Waller, J.L. Atkins, D. Swinson, K.J. O'Byrne, M.D. Peake [Lung Cancer 46 (2) (2004) 227-232.]Linnane, S. / O'Keefe, P. et al. | 2005
- 427
-
AUTHORS REPLYWaller, D. A. et al. | 2005
- 429
-
Cross-talk between cyclooxygenase-2 and epidermal growth factor receptor in non-small cell lung cancerAltundag, O. / Altundag, K. / Boruban, C. / Silay, Y. S. et al. | 2005
- S1
-
E1. Improving cancer management with reference to resourcesAbratt, R. P. et al. | 2005
- S3
-
Asbestos and mesothelioma: Worldwide trendsKazan-Allen, L. et al. | 2005
- S3
-
Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)Rosell, R. / de Lena, M. / Carpagnano, F. / Ramlau, R. / Gonzalez-Larriba, J. / Grodzki, T. / Le Groumellec, A. / Aubert, D. / Gasmi, J. / Douillard, J. et al. | 2005
- S3
-
E2. Current research in lung cancer is inefficient and usually irrelevant: ForArriagada, R. et al. | 2005
- S5
-
E3. Lung cancer in Latin America: A perspectiveArriagada, R. et al. | 2005
- S6
-
O-007 Low frequency of epidermal growth factor receptor gene mutations in non-small cell lung cancers in KoreaLee, J. / Kim, H. / Lee, D. / Lee, S. / Park, K. / Han, J. / Hong, E. / Ro, J. / Zo, J. et al. | 2005
- S7
-
O-011 Gene mutations indicate different pathways to lung cancers innever and ever smokersShigematsu, H. / Nomura, M. / Suzuki, M. / Lee, H. / Wistuba, I. / Fong, K. / Toyooka, S. / Shimizu, N. / Minna, J. / Gazdar, A. et al. | 2005
- S8
-
O-014 Finding biomarkers specific for early stages of lung cancer usingSAGE dataChan, T. / MacAulay, C. / Lam, W. / Lam, S. / Lonergan, K. / Ng, R. et al. | 2005
- S9
-
O-017 Lung adenocarcinomas with mutations in EGFR and KRAS havedistinct gene expression profilesPham, D. / Sarkaria, I. / Socci, N. / Pao, W. / Zakowski, M. / Miller, V. / Kris, M. / Rusch, V. / Singh, B. et al. | 2005
- S9
-
Asbestos problem in IndiaSubramanian, V. / Madhavan, N. et al. | 2005
- S10
-
O-021 Prognostic and predictive role of alterations of the P53-bax-bcl2pathway of apoptosis in the IALT (International Adjuvant Lung Cancer Trial)Brambilla, E. / Dunant, A. / Filipits, M. / Lantuejoul, S. / Tarayre, M. / David-Boudet, L. / Pirker, R. / Soria, J. / Pignon, J. / Le Chevalier, T. et al. | 2005
- S10
-
E7. The IASLC staging project: non-small cell lung cancer: a radiation oncologist's perspectiveBall, D. L. et al. | 2005
- S11
-
O-025 Tumor ablation through self-expandable metal stent (SEMS) forairway neoplasm: The dosimetry and efficacy of photodynamic therapyDownie, G. / Yu Ya, H. / Xin-Hua, H. / Claudio, S. / Ron, A. / Rosa, C. / Carter, C. et al. | 2005
- S12
-
E8. Bronchoscopic biopsy of isolated, peripheral lung lesions underendobronchial ultrasound (EBUS) and electromagnetic guidanceBecker, H. D. et al. | 2005
- S12
-
O-028 Rigid bronchoscopic intervention in patients with respiratoryfailure due to malignant central airway obstructionKim, H. / Jeon, K. / Yu, C. / Koh, W. / Suh, G. / Chung, M. / Kwon, O. et al. | 2005
- S13
-
Epidemiology of mesothelioma-a South African perspectiveAbratt, R. P. / White, N. W. / Vorobiof, D. A. et al. | 2005
- S14
-
E9. Expression profiling of lung cancer and its clinical implicationsBeer, D. G. et al. | 2005
- S16
-
E10. The investigation of bronchial epithelia from lung cancer patients: A better way of understanding lung cancer biologyBetticher, D. C. / Heighway, J. et al. | 2005
- S17
-
Epidemic of mesothelioma in EgyptGaafar, R. M. / Eldin, N. H. et al. | 2005
- S17
-
O-044 Storage of plasma or isolated plasma DNA affects the results ofcirculating DNA quantification assaysAndriani, F. / Conte, D. / Roz, L. / Mariani, L. / Pastorino, U. / Sozzi, G. et al. | 2005
- S18
-
E11. New targets and new agents on the horizon for lung cancer therapyBunn, P. A. et al. | 2005
- S18
-
O-047 International multicenter randomized double-blind placebo-controlled phase 3 clinical trial of INS316 as an adjunct for acquiring deep-lung sputum specimens for the cytological diagnosis of lung cancerJohnson, F. / Yung, R. / Sussman, R. / Kellerman, D. / Durham, T. / Gorden, J. et al. | 2005
- S19
-
O-049 Affymetrix gene expression profiles in premalignant bronchialmucosaMerrick, D. / Sugita, M. / Hirsch, F. / Keith, R. / Miller, Y. / Coldren, C. / Lapadat, R. / Witta, S. / Geraci, M. / Franklin, W. et al. | 2005
- S20
-
O-051 Was overdiagnosis responsible for spurious survival advantages in randomized trials of lung cancer screening? — Public policy implicationsStrauss, G. / Babbitt, D. / Dominioni, L. et al. | 2005
- S21
-
Mesothelioma, perspective from the industryGruber, U. F. et al. | 2005
- S21
-
O-055 Dietary phytoestrogens and lung cancer riskSchabath, M. / Hernandez, L. / Pillow, P. / Wu, X. / Spitz, M. et al. | 2005
- S22
-
O-058 Characteristics of lung cancer patients who were diagnosed younger than 50 or older than 80 years of ageYang, P. / Visbal, A. / Ebbert, J. / Zhang, Z. / Molina, J. / Williams, B. / Sheu, S. / Wampfler, J. / Nichols, F. et al. | 2005
- S22
-
E14. Optimization of thoracic irradiation: An overviewByhardt, R. W. et al. | 2005
- S23
-
O-061 Frequency and costs of multiple skeletal complications inpatients with bone metastases of lung cancerDelea, T. / McKiernan, J. / Gokhale, M. / Edelsberg, J. / Brandman, J. / Sung, J. / Raut, M. / Oster, G. et al. | 2005
- S25
-
E16. 4D CT (Computed Tomography) improves TCP without an increase in NTCP of lung when compared with helical CT planning in 3D conformal radiation therapy (CRT) for patients with lung cancerChoi, N. C. / Wolfgang, J. / Flampouri, S. / Patel, A. / Jiang, S. / Niemierko, A. / Chen, G. T. et al. | 2005
- S25
-
O-068 Sensitivity of FDG-PET in the diagnostic evaluation of small pulmonary nodulesDaniels, C. / Lowe, V. / Jett, J. et al. | 2005
- S25
-
Imaging, staging and response evaluationByrne, M. / Hillerdal, G. et al. | 2005
- S27
-
The role of PET in the surgical management of malignant pleural mesotheliomaFlores, R. M. et al. | 2005
- S27
-
O-074 Comparison of FDG-PET and CT scans to assess response to chemotherapy in patients with malignant pleural mesotheliomaByrne, M. / Francis, R. / van der Schaaf, A. / Boucek, J. / Price, R. / Patrikeos, A. / Musk, A. / Millward, M. et al. | 2005
- S28
-
E18. Thoracoscopic lobectomy (syllabus)D'Amico, T. et al. | 2005
- S28
-
O-077 Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind placebo-controlled, randomized phase II trialKindler, H. / Lu, C. / Gandara, D. / Stevenson, J. / Krug, L. / Janne, P. / Gitlitz, B. / Karrison, T. / Stadler, W. / Vokes, E. et al. | 2005
- S29
-
O-081 IMRT after extrapleural pneumonectomy prevents local recurrence of mesotheliomaStevens, C. / Rice, D. / Forster, K. / Zhu, X. / Smythe, W. et al. | 2005
- S32
-
O-090 Weekly vinorelbine plus cisplatin versus day 1+8 vinorelbine withcisplatin in advanced non small cell lung cancer: End results of a phase III trialGebbia, V. / Galetta, D. / Caruso, M. et al. | 2005
- S32
-
E21. Carboplatin versus cisplatin in lung cancerEinhorn, L. H. et al. | 2005
- S33
-
Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imagingSteinert, H. C. / Dellea, M. M. / Burger, C. / Stahel, R. et al. | 2005
- S34
-
O-097 A randomized phase III trial of six versus four cycles ofchemotherapy: Optimal duration of chemotherapy in advanced non-small-cell lung cancer: Korea cancer study group experiencePark, J. / Kim, S. / Jang, J. / Cho, E. / Yang, S. / Choi, J. / Heo, D. / Shin, S. / Yun, Y. / Park, K. et al. | 2005
- S35
-
O-100 ZD6474 plus docetaxel in patients with previously treatedNSCLC: Results of a randomized, placebo-controlled Phase II trialHerbst, R. / Johnson, B. / Rowbottom, J. / Fidias, P. / Lu, C. / Prager, D. / Roubec, J. / Csada, E. / Dimery, I. / Heymach, J. et al. | 2005
- S36
-
E22. Reimbursement policies, research andprescribing practices: The Canadian perspectiveEvans, W. K. / Graham, I. et al. | 2005
- S37
-
CT, RECIST, and malignant pleural mesotheliomaNowak, A. K. et al. | 2005
- S38
-
E23. Report of the Spanish Neuroendocrine Lung Tumors RegistryGarcí / a-Yuste, M. et al. | 2005
- S38
-
O-109 Phase II trial of erlotinib in patients with bronchioloalveolarcarcinomaSandler, A. / Kris, M. / Miller, V. / Carbone, D. / Pao, W. / Billheimer, D. / Tsao, A. / Patel, J. / Johnson, B. / Johnson, D. et al. | 2005
- S39
-
O-112 Microsatellite alterations and P53 mutations in tumor and plasma DNA of resected non small cell lung cancer (NSCLC) patients. (A study of the Perugia Multidisciplinary team for thoracic tumors)Darwish, S. / Ludovini, V. / Pistola, L. / Piattoni, S. / Di Carlo, L. / Rulli, E. / Ferraldeschi, M. / Tofanetti, F. / Sheibel, M. / Tonato, M. et al. | 2005
- S40
-
E24. The IASLC Staging Project: an overview of progress to dateGoldstraw, P. et al. | 2005
- S41
-
O-119 Preoperative SUV of NSCLC is an independent predictor of early recurrence after complete resectionBaek, H. / Koh, J. / Kim, S. / Cheon, G. / Choe, D. / Choi, C. / Lim, S. et al. | 2005
- S41
-
Computerized analysis of mesothelioma on CT scansArmato, S. G. et al. | 2005
- S42
-
O-122 Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targetsPetersen, R. / Bild, A. / Dressman, H. / Joshi, M. / Conlon, D. / West, M. / Nevins, J. / Harpole, D. et al. | 2005
- S42
-
E25. Chemotherapy in elderly patientsGridelli, C. et al. | 2005
- S43
-
O-126 Expression profiling of matrix metalloproteinases (MMPs) and inhibitors reveals a novel prognostic role for MMP-19 in patients with non-small cell lung cancerBlackhall, F. / Pintilie, M. / Liu, N. / Pennington, C. / Zhu, C. / Shepherd, F. / Edwards, D. / Tsao, M. et al. | 2005
- S44
-
O-129 Genes highly expressed in the preinvasive stage of lungadenocarcinoma (atypical adenomatous hyperplasia)Noguchi, M. / Sato, S. / Kano, J. / Anami, Y. / Iijima, T. / Morishita, Y. / Inadome, Y. et al. | 2005
- S44
-
E26. Early stage peripheral lesionHerth, F. J. et al. | 2005
- S45
-
O-132 Defining characteristics of the EGFR gene mutation in NSCLCTsao, A. / Sabloff, B. / Shigematsu, H. / Xiao, L. / Hong, W. / Gazdar, A. / Wistuba, I. et al. | 2005
- S45
-
Malignant pleural mesothelioma: Staging systemsSchil, P. V. et al. | 2005
- S47
-
E28. Chemoprevention of lung cancer: Intermediate endpoints for chemoprevention trialsHirsch, F. R. et al. | 2005
- S47
-
O-139 Extracranial stereotactic radiation therapy (ESRT) in primary andmetastatic lung tumorsRicardi, U. / Guarneri, A. / Giglioli, F. / Filippi, A. / Mantovani, C. / Ragona, R. et al. | 2005
- S48
-
O-141 Symptomatic and edoscopic response in primary lung cancerpatients following endobronchial brachytherapy: An evaluation of 166 casesKarakoyun Celik, O. / Goksel, T. / Mogulkoc, N. / Anacak, Y. / Cok, G. / Haydaroglu, A. / Ozkok, S. et al. | 2005
- S49
-
Prognostic factors in mesotheliomaSteele, J. P. / Klabatsa, A. / Fennell, D. A. / Pallaska, A. / Sheaff, M. T. / Evans, M. T. / Shamash, J. / Rudd, R. M. et al. | 2005
- S50
-
O-147 Metabolic PET imaging for stereotactic body radiation therapyplanning and therapy response assessment of pulmonary malignanciesFuss, M. / Salter, B. / Thomas, C. et al. | 2005
- S51
-
O-150 Intensity modulated post-operative radiation therapy for locally advanced non-small cell lung cancerRosenzweig, K. / Gupta, V. / Jackson, A. / Choy, H. / Yorke, E. et al. | 2005
- S52
-
E32. Advances in endoscopic diagnosis of early lesions of the bronchusIkeda, N. / Honda, H. / Hayashi, A. / Usuda, J. / Tsuboi, M. / Ohira, T. / Hirano, T. / Kato, H. et al. | 2005
- S52
-
O-153 Phase III randomised trial of doxorubicin based chemotherapy compared with platinum based chemotherapy in both limited and extensive stage patientsBaka, S. / Lorigan, P. / Papakotoulas, P. / Rehman, S. / Lau, S. / Anderson, H. / Finn, C. / Ashcroft, L. / Thatcher, N. et al. | 2005
- S53
-
Molecular prognostic markers in malignant mesotheliomaKumar, P. / Kratzke, R. A. et al. | 2005
- S53
-
O-156 Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)Langer, C. / Hanna, N. / Einhorn, L. / Sandler, A. / Ansari, R. / Ellis, P. / Byrne, M. / Green, M. / Morrison, M. / Bunn, P. et al. | 2005
- S54
-
O-159 A prospective randomized phase III, double-blind, placebo-controlled study of thalidomide in extended-disease (ED) SCLC patients after response to chemotherapy (CT)Pujol, J. / Breton, J. / Gervais, R. / Tanguy, M. / Quoix, E. / David, P. / Janicot, H. / Depierre, A. / Gameroft, S. / Geneve, J. et al. | 2005
- S54
-
E33. Pet scanning for evaluation of solitary pulmonary nodule and staging of NSCLCJett, J. R. et al. | 2005
- S55
-
O-162 Optimal pain control for radiation induced oesophagitis: Anevidence based approach or a lucky dip?Duffy, M. et al. | 2005
- S56
-
O-166 Validity of one-item scale for rapid screening of fatigue in thoracic oncology patientsPirl, W. / Temel, J. / Cashavelly, B. / Lynch, T. et al. | 2005
- S57
-
O-170 The natural history of carcinoma in situ involving bronchial resection marginsPasic, A. / Grü / nberg, K. / Mooi, W. / Paul, M. / Postmus, P. / Sutedja, T. et al. | 2005
- S59
-
O-177 Prediction of lymph node metastasis by combined analysis using chest CT and mRNA expression profile in non-small cell lung cancerChang, J. / Kim, J. / Choi, Y. / Han, J. / Lee, K. et al. | 2005
- S60
-
E38. Molecular predictors of outcome for lung cancerKratzke, R. A. et al. | 2005
- S60
-
O-181 Developing a strategy to increase lung cancer resection ratesO'Rourke, N. / Buchanan, S. et al. | 2005
- S61
-
Chemotherapy for malignant mesotheliomaBaas, P. et al. | 2005
- S61
-
O-185 Overcoming hypothesized antagonism with intermittent dosingof erlotinib in combination with docetaxel (DOC) in non-small cell lung cancer (NSCLC): A phase I studyDavies, A. / Lara, P. / Lau, D. / Mack, P. / Gumerlock, P. / Gandara, D. et al. | 2005
- S62
-
O-188 Phase II study of the EGFR tyrosine kinase inhibitor erlotinib (Tarceva) in patients >70 years of age with previously untreated advanced non-small cell lung carcinomaJackman, D. / Lucca, J. / Fidias, P. / Rabin, M. / Lynch, T. / Ostler, P. / Skarin, A. / Temel, J. / Johnson, B. / Janne, P. et al. | 2005
- S63
-
O-191 HER1-HER2-HER3 gene amplification and akt activation inpatients with advanced non-small cell lung cancer (NSCLC) treated with gefitinibCappuzzo, F. / Varella-Garcia, M. / Toschi, L. / Domenichini, I. / Ceresoli, G. / Gregorc, V. / Franklin, W. / Crinò / L. / Bunn, P. et al. | 2005
- S64
-
E41. Dilemmas in management: The controversial role of chemotherapy in PS 2 advanced NSCLCLanger, C. J. et al. | 2005
- S64
-
O-193 Novel semaphorin- and juxtamembrane-domain mutations ofc-MET in NSCLC: Potential for targeted inhibitionMa, P. / Dietrich, S. / Fox, E. / Naoki, K. / Schaefer, E. / Lader, A. / Richards, W. / Sugarbaker, D. / Jagadeeswaran, R. / Salgia, R. et al. | 2005
- S65
-
Photodynamic therapy as an adjunct to surgery for malignant pleural mesotheliomaRis, H. B. et al. | 2005
- S65
-
O-196 Treatment with gleevec in non-small cell lung cancer isassociated with decrease of PDGF-rb and VEGF expression, decrease in IFP and improvement of tumor oxygenationVlahovic, G. / Rabbani, Z. / Dewhirst, M. / Vujaksovic, Z. et al. | 2005
- S67
-
PD-003 In vivo evidence for EGFR-Stat3 survival signaling in early stage NSCLCBepler, G. / Zheng, Z. / Cantor, A. / Haura, E. et al. | 2005
- S68
-
PD-006 2-Methoxyestradiol (2-ME2, Panzem®) and its new derivatives inhibited lung cancer cells in vitro and prolonged survivals in athymic nude rats with orthotopic lung tumors in vivoChan, D. / LaVallee, T. / Zhang, Z. / Zhao, L. / Swartz, G. / Treston, A. / Fogler, W. / Bunn, P. et al. | 2005
- S69
-
E42. Global perspectives on lung cancer. Asian perspectivesSoo Lee, J. et al. | 2005
- S69
-
PD-010 Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapyGiachino, D. / Ghio, P. / Regazzoni, S. / Mandrile, G. / Novello, S. / Selvaggi, G. / De Marchi, M. / Scagliotti, G. et al. | 2005
- S69
-
Neoadjuvant chemotherapy in malignant pleural mesotheliomaStahel, R. / Weder, W. et al. | 2005
- S70
-
PD-014 Relation between ERCC1 expression in sputum and survivalafter cisplatin-based chemotherapy in patients with non-small cell lung cancerJung, M. / Kim, J. / Kim, H. / Oak, C. / Jang, T. / Jeon, Y. / Jeon, C. et al. | 2005
- S71
-
PD-018 Real-time quantification of CK-19 mRNA-positive cells inperipheral blood of patients using with non-small cell lung cancer (NSCLC) using Real Time RT-PCRMilaki, G. / Mavroudis, D. / Apostolaki, S. / Souglakos, I. / Perraki, M. / Georgoulias, V. et al. | 2005
- S71
-
Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experienceFlores, R. M. et al. | 2005
- S71
-
E43. Pharmacogenomic and molecular basis for responsivenessto present combination chemotheraphy with or without targeted agentsLynch, T. et al. | 2005
- S72
-
PD-021 Tissue microarray for protein profiling in non-small cell lungcancer (NSCLC): Discovery and validation of novel biomarkers for prediction of recurrence and treatment responseRobert, F. / Robert, S. / deShazo, M. / Reddy, V. / Diasio, R. / Ezzeldin, H. / Carey, D. / Chen, D. / Schreeder, M. / Ross, D. et al. | 2005
- S73
-
PD-024 Expression of High Mobility Group A proteins in lung cancer correlates with survivalSarhadi, V. / Wikman, H. / Salmenkivi, K. / Kuosma, E. / Sioris, T. / Salo, J. / Karjalainen, A. / Knuutila, S. / Anttila, S. et al. | 2005
- S74
-
E45. Role of PET-CT in the optimization of thoracic radiotherapyMacManus, M. et al. | 2005
- S75
-
PD-032 Wnt2 as a new therapeutic target in malignant pleural mesotheliomaXu, Z. / Mazieres, J. / He, B. / You, L. / Jablons, D. et al. | 2005
- S75
-
Treatment planning system evaluation for mesothelioma IMRTStevens, C. W. / Wong, P. F. / Rice, D. / Jeeter, M. / Forster, K. / Zhu, X. R. et al. | 2005
- S76
-
PD-036 Loco-regional progression after induction chemotherapy maypredict the development of M1 disease after the initiation of concurrent chemo-radiation in stage III NSCLCBasir, S. / Fossella, F. / Hwang, L. / Lu, C. / Kornaki, R. / Zinner, R. et al. | 2005
- S78
-
PD-043 Post surgical adjuvant chemo-immunotherapy by activated autologous killer cells and dendritic cells from regional lymph nodes of the lung cancer patientsKimura, H. et al. | 2005
- S79
-
PD-046 Phase II randomized trial adding a toll-like receptor 9 agonist (ProMuneTM) to first line chemotherapy shows improved response in advanced non-small cell lung cancerManegold, C. / Leichman, G. / Gravenor, D. / Woytowitz, D. / Mezger, J. / Haarmann, C. / Al-Adhami, M. / Schmalbach, T. / Whisnant, J. et al. | 2005
- S80
-
PD-050 A phase II trial of pre-operative chemoradiotherapy followedby surgical resection in Pancoast tumors: Report of a Japan Clinical Oncology Group trial (JCOG 9806)Suzuki, K. / Kunitoh, H. / Kato, H. / Tsuboi, M. / Ishizuka, N. / Asamura, H. / Ichmose, Y. / Katakami, N. / Saijo, N. et al. | 2005
- S81
-
PD-053 Lung cancer susceptibility: A CDKN1A promoter polymorphismenhances the risk for lung cancerField, J. / Xinarianos, G. / Myles, J. / Nikolaidis, G. / Cassidy, A. / Duffy, S. / Liloglou, L. et al. | 2005
- S82
-
E52. Restaging after induction treatment: Surgical techniquesRami-Porta, R. x. et al. | 2005
- S83
-
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experienceMunter, M. W. / Christian, T. / Anna, N. / Simeon, N. / Jurgen, D. et al. | 2005
- S84
-
PD-063 Kinetic model of survival for advanced non-small cell lungcancer (NSCLC) predicts enrichment-bias affects 2nd Line treatment trialsAkerley, W. / Major, M. / Maul, S. et al. | 2005
- S85
-
PD-066 Does reporting expected duration and severity of adverseevents provide clinically relevant information when selecting a chemotherapy regimen? An example using pemetrexed and docetaxelBhalla, S. / Thatcher, N. / Reck, M. / Tilden, D. / Gatzemeier, U. / Stynes, G. / Leschinger, M. / Fitzgerald, P. et al. | 2005
- S85
-
E54. Tumor suppressor pathways in lung cancer: A genomic and genetic approachSanchez-Cespedes, M. et al. | 2005
- S86
-
PD-069 Quality-of-Life (COL) assessment in two docetaxel dose-schedulesas second-line treatment of advanced non small cell lung cancer (NSCLC): Spanish Lung Cancer Group (SLCG) Phase III trialCamps, C. / Massuti, B. / Jimé / nez, A. / Maestu, I. / Garcia, R. / Isla, M. / Gonzá / lez-Larriba, J. / Almenar, D. et al. | 2005
- S87
-
PD-072 Circulating nucleosomes and cyfra 21-1 predict early theresponse to chemotherapy in patients with advanced non-small cell lung cancerHoldenrieder, S. / Stieber, P. / von Pawel, J. / Raith, H. / Nagel, D. / Feldmann, K. / Seidel, D. et al. | 2005
- S88
-
PD-075 Consolidation docetaxel (D) following concurrentchemoradiotherapy (chemoRT) in stage IIIB non-small cell lung cancer (NSCLC): Updated five-year survival results from Southwest Oncology Group trial S9504Lara, P. / Chanski, K. / Gaspar, L. / Albain, K. / Crowley, J. / Gandara, D. et al. | 2005
- S89
-
PD-078 Primary treatment for patients (pts) with advanced NSCLCpresenting with brain metastasis (BMs) at first diagnosis. Final results from a multi-institutional survey by oncologic centers participating to the ReVERTO (Rete per la Valutazione dell'Efficacia nella Ricerca dei Trattamenti Oncologici) Italian NetworkPollera, C. / Rinaldi, M. / Ceribelli, A. / De Marinis, F. / Cortesi, E. / Gamucci, L. / Tonini, G. / Viola, G. / Sperduti, I. / Moscetti, L. et al. | 2005
- S89
-
Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma-a new model for the study of tumor biology and disease progressionDavidson, B. / Vintman, L. / Nielsen, S. / Reich, R. / Berner, A. et al. | 2005
- S90
-
PD-081 A phase 2 randomized study of GM-CSF gene-modifiedautologous tumor vaccine (CG8123) with and without low-dose cyclophosphamide in advanced stage non-small cell lung cancer (NSCLC)Schiller, J. / Nemunaitis, J. / Ross, H. / Jablons, D. / Harper, H. / Sterman, D. / Kelly, K. / Carbone, D. / Lin, A. / Hege, K. et al. | 2005
- S91
-
PD-084 Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)Abratt, R. / Lee, J. / Han, J. / Tsai, C. / Boyer, M. / Mok, T. / Kim, S. / Brnabic, A. / Lehnert, M. et al. | 2005
- S92
-
E60. Restaging after induction therapyVan Schil, P. et al. | 2005
- S93
-
PD-091 Pretreatment prognostic factors in patients with early stage(VII) nonsmall cell lung cancer treated wth hyperfactionated radiation therapy aloneJeremic, B. / Milicic, B. / Dagovic, A. / Radosavljevic-Asic, G. et al. | 2005
- S94
-
PD-094 Prognostic value of visceral pleural invasion in resected non-small cell lung cancer using a jet stream of saline solutionMaruyama, R. / Shoji, F. / Okamoto, T. / Miyake, T. / Aoki, Y. / Wataya, H. / Ichinose, Y. et al. | 2005
- S94
-
E61. PET scan: Current recommendations and innovationVansteenkiste, J. et al. | 2005
- S95
-
PD-098 Initial results of pre-operative pulmonary function testing in patients with stage I–II Non-Small Cell Lung Cancer (NSCLC) treated with neoadjuvant chemotherapy with gem citabine-containing regimensRivera, M. / Detterbeck, F. / Socinski, M. / Moore, D. / Edelman, M. / Jahan, T. / Ansari, R. / Luketich, J. / Obasaju, C. / Gralla, R. et al. | 2005
- S95
-
Implications of P16/CDKN2A deletion in pleural mesotheliomasLadanyi, M. et al. | 2005
- S96
-
PD-101 Review of practice patterns for adjuvant chemotherapy inpatients with completely resected non-small cell lung cancer (NSCLC)Visbal, A. / Kassam, F. / Johnston, M. / Feld, R. / Shepherd, F. / Darling, G. / Keshavjee, S. / Pierre, A. / Waddell, L. / Leighl, N. et al. | 2005
- S97
-
PD-104 The implementation of 40 CT using a novel respiratory motionmodelling technique to aid radiotherapy planning in patients with Non-small cell lung cancerAhmad, S. / McClelland, J. / Chandler, A. / Blackall, J. / Landau, D. / Hawkes, D. et al. | 2005
- S98
-
PD-107 Decreasing lung exposure of patients suffering from advancedNSCLC by palliative irradiation in sitting positionDuisters, C. / Beurskens, H. / Nijsten, S. / Starmans, M. / Wanders, S. / Boersma, L. / Verschueren, T. / Lambin, P. / Minken, A. / De Ruysscher, D. et al. | 2005
- S99
-
Author index| 2005
- S99
-
PD-110 The clinical implementation of respiratory gated intensitymodulated radiotherapyKeall, P. / Vedam, S. / George, R. / Siebers, J. / Chung, T. et al. | 2005
- S99
-
Transcriptional profiling of mesothelioma using microarraysGordon, G. J. et al. | 2005
- S101
-
PD-118 High dose rate endobronchial brachytherapy (HDREB) in the palliation of patients with non-small cell lung cancer (NSCLC): A systematic reviewUng, Y. / Yu, E. / Falkson, C. / Laetsch, N. / Haynes, A. / Evans, W. / Mackay, J. et al. | 2005
- S103
-
PD-125 Efficacy of wedge resection of lung cancer: Ten year survivalGriffin, J. / Eastridge, C. / Tolley, E. et al. | 2005
- S104
-
PD-129 Significant impact of tumor size on 5-year survival of non smallcell lung cancer patients with stage T1N0M0 after lobectomiesKshivets, O. et al. | 2005
- S105
-
Apoptosis regulation and drug resistance in malignant pleural mesotheliomaZangemeister-Wittke, U. / Hopkins-Donaldson, S. et al. | 2005
- S105
-
PD-132 Diffusion lung capacity for carbon monoxide (DLCO) and notFEV1 correlates with long term survival in patients after lung cancer resectionLiptay, M. / Merwitz, E. / Alwawi, E. / Hoaglin, M. / Culiner, K. / Hensing, T. / Hammoud, Z. et al. | 2005
- S107
-
PD-141 Feasibility of limited resection for peripheral small lung cancer with regard to CT image and tumor differentiationYoon, H. / Sakamaki, Y. / Oda, N. / Ueshima, H. / Sugiura, T. / Kaneda, H. / Shimamoto, S. / Imakita, M. et al. | 2005
- S108
-
PD-144 Tumor response augmentation with combination cetuximab(Erbitux®) and bevacizumab (Avastin®)Hoang, T. / Huang, S. / Armstrong, E. / Eickhoff, J. / Harari, P. et al. | 2005
- S109
-
Soluble mesothelin-related protein-A blood test for mesotheliomaRobinson, B. W. / Creaney, J. / Lake, R. / Nowak, A. / Musk, A. W. / de Klerk, N. / Winzell, P. / Hellstrom, K. E. / Hellstrom, I. et al. | 2005
- S110
-
PD-151 Mutations in the epidermal growth factor receptor (EGFR): Retro-and prospective observations in non-small cell lung cancer (NSCLC) patients (pts) treated with gefitinibNederlof, P. / Boerrigter, L. / van 't Veer, L. / Baas, P. / van Zandwijk, N. et al. | 2005
- S111
-
PD-154 An open-label, multi centre phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)Reck, M. / Buchholz, E. / Gahlemann, C. / Gatzemeier, U. / Manegold, C. et al. | 2005
- S112
-
PD-158 Mutations in the EGFR gene as predictors of gefitinib-sensitivity specifically occur in lung adenocarcinoma patients with a relatively low exposure of tobacco smokingSugio, K. / Uramoto, H. / Hanagiri, T. / Oyama, T. / Yoshimatsu, T. / Sugaya, M. / Ono, K. / Nakata, S. / Morita, M. / Yasumoto, K. et al. | 2005
- S113
-
Clinical trials in malignant pleural mesothelioma in AustralasiaNowak, A. K. et al. | 2005
- S115
-
P-004 Role of vascular endothelial growth factor (VEGF) in the diagnosis of malignant pleural effusionsBehera, D. / Reddy, C. / Dash, S. et al. | 2005
- S116
-
P-008 Tumour expression and activity of MMP-2 and MMP-9metalloproteinases in non-small cell lung cancer according to TFPI-2 gene expressionBlechet, C. / Rollin, J. / Iochmann, S. / Ré / gina, S. / Lemarié / E. / Reverdiau, P. / Guyé / tant, S. et al. | 2005
- S117
-
P-011 Identification of genomic changes associated with resistance tostandard chemotherapy in a xenograft model of human NSCLCBuys, T. / Wang, Y. / Yee, J. / English, J. / Flint, J. / Murray, N. / Garnis, C. / Guan, J. / MacAulay, C. / Ling, V. et al. | 2005
- S117
-
Overview on ongoing or planned clinical trials in EuropeFavaretto, A. et al. | 2005
- S118
-
P-014 Discriminate capacity of VEGFs and VEGFRs in lung cancer. Arethe different subtypes outstanding?Carrillo de Santa Pau, E. / Toledo Lobo, M. / Caso Pelá / ez, E. / Pé / rez Rodrí / guez, E. / Sá / nchez Herná / ndez, I. et al. | 2005
- S119
-
P-017 Effect of inhaled budesonide in smokers with bronchial dysplasiaChari, R. / Lonergan, K. / Girard, L. / Minna, J. / Gazdar, A. / Ng, R. / Lam, W. / MacAulay, C. / Lam, S. et al. | 2005
- S121
-
P-025 Fine mapping of SCLC tumors and cell lines by high resolutionarray CGH identifies novel alterationsCoe, B. / Lee, E. / Grand, L. / Gazdar, A. / Minna, J. / Lam, S. / MacAulay, C. / Tsao, M. / Lam, W. et al. | 2005
- S122
-
P-029 MDM2 gene amplification and expression in NSCLC cells: Biological and clinical implicationsDworakowska, D. / Jassem, E. / Jassem, J. / Schneider-Stock, R. / Boltze, C. / Wiedorn, K. / Skokowski, J. / Jaskiewicz, K. / Czestochowska, E. et al. | 2005
- S123
-
P-034 Occupational lung cancer: Application of microarray technology for monitoring gene expression patterns in chromate-related lung cancerEwis, A. / Kondo, K. / Shinohara, Y. / Ishikawa, M. / Baba, Y. et al. | 2005
- S123
-
Consensus report: Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomavan Meerbeeck, J. P. / Boyer, M. et al. | 2005
- S124
-
P-038 Expression of hypoxia induceible factor-1 alpha is associatedwith poor prognosis in non-small cell lung cancerFujita, Y. / Fujiuchi, S. / Nishigaki, Y. / Kurihara, M. / Yamamoto, Y. / Takeda, A. / Yamazaki, Y. / Nagase, A. / Fujikane, T. / Shimizu, T. et al. | 2005
- S125
-
P-042 In vivo molecular profiling of tissue level responses in support of the evaluation of new systemic agents in combined modality therapy in the treatment of non-small cell lung carcinomaGoldberg, Z. / Schwietert, C. / Isbell, M. / Lehmann, J. / Stern, R. / Jones, A. / Rocke, D. et al. | 2005
- S126
-
P-047 Growth inhibition and apoptosis induction of protopanaxtriol onhuman lung cancer cellsHe, J. / Gou, H. / Wang, Z. / Liu, K. et al. | 2005
- S127
-
P-051 Expression of L1CAM in non-small cell lung cancerHirai, K. / Koizumi, K. / Haraguchi, S. / Hirata, T. / Mikami, I. / Fukushima, M. / Kawashima, T. / Yamagishi, S. / Shimizu, K. et al. | 2005
- S128
-
P-055 Increased expression of collagen XVIII is associated with poor outcome and chemosensitivity in non-small cell lung carcinomaIizasa, T. / Chang, H. / Suzuki, M. / Iyoda, A. / Shibuya, K. / Hiroshima, K. / Nakatani, Y. / Hiwasa, T. / Takiguchi, M. / Fujisawa, T. et al. | 2005
- S130
-
P-064 The apoptotic mechanism of chloramquinone in human non-small cell lung cancer A549 cellsKim, S. / Lim, J. et al. | 2005
- S131
-
P-068 Comparison of tumor-infiltrating and peripheral blood cytotoxicT lymphocyte phenotypes in non-small cell lung cancer patientsKrawczyk, P. / Chocholska, S. / Rojowski, A. / Gozdziuk, K. / Milanowski, J. et al. | 2005
- S132
-
P-072 Gene expression profiling in lung adenocarcinomas revealsmolecular signatures with respect to gender, smoking, tumor grading and disease-free survivalIam, C. / Wong, M. / Girard, L. / Chiu, S. / Suen, W. / Lam, W. / Minna, J. et al. | 2005
- S134
-
P-079 Validation of genes associated with Achaete-scute Homologue-1that regulate the growth of pulmonary neuroendocrine carcinomas in mice and menLinnoila, I. / Kim, H. / Wang, X. / Dakir, E. / DeMayo, F. et al. | 2005
- S135
-
P-083 Chromosomal imbalances in the multistage development ofsquamous cell lung cancerMa, J. / Feng, X. / Zhang, J. / Cheng, S. / Gao, Y. et al. | 2005
- S137
-
P-091 Targeting small cell lung cancer with virus-specific CD8+cytotoxic t lymphocytesMoss, A. / Aladin, F. / Marshal, E. / Blake, N. / Coulson, J. et al. | 2005
- S139
-
P-098 Cytochrome P450 2A6 and 3A expression in non-small cell lung cancerOyama, T. / Sugio, K. / Uramoto, H. / Nakata, S. / Ono, K. / Yoshimatsu, T. / Osaki, T. / Isse, T. / Kawamoto, T. / Yasumoto, K. et al. | 2005
- S140
-
P-101 Significance of the correlation between the expression ofinterleukin 6 and clinical features in patients with non-small cell lung cancerKoh, E. / Iizasa, T. / Yamaji, H. / Suzuki, M. / Chang, H. / Yokoi, S. / Hiroshima, K. / Nakatani, Y. / Fujisawa, T. et al. | 2005
- S141
-
P-105 Proof-of principle clinical trial uncovers cyclin D1 repression as a biomarker of erlotinib responsePetty, J. / Dragnev, K. / Memoli, V. / Iwata, K. / Rigas, J. / Dmitrovsky, E. et al. | 2005
- S142
-
P-108 A fixed dose combination comprising liposomal carboplatin andliposomal innotecan for the treatment of a mutine model of NSCLCRamsay, E. / Anantha, M. / Van Tienen, I. / Osooly-Talesh, M. / Laskin, J. / Bally, M. et al. | 2005
- S143
-
P-111 Identification of optimal housekeeping genes for gene expression profiling in non-small cell lung cancerSaviozzi, S. / Volante, M. / Lo Iacono, M. / Papotti, M. / Scagliotti, G. / Novello, S. / Bacillo, E. / Calogero, R. et al. | 2005
- S144
-
P-113 Role of tumour necrosis factor a-gene polymorphisms (-238 and-308) in non-small cell lung cancer susceptibility and severityShih, C. / Lee, Y. et al. | 2005
- S146
-
P-121 What is the clinical significance of serum carcinoembryonicantigen (CEA) and cytokeratin 19 fragments (Cyfra 21-1) elevation in operable non small cell lung cancer (NSCLC) patients?Szturmowicz, M. / Rudzinski, P. / Kacpizak, A. / Langfort, R. / Bestry, I. / Demkow, U. / Orlowski, T. et al. | 2005
- S147
-
P-125 p-38 MAPK, Erk and Akt expression and activation in NSCLCtumors; Subcellular distribution and radiographic response to radiotherapyTsakiridis, T. / Wright, J. / Vincic, L. / Junejo, M. / Tsiani, E. / Aljamad, H. / Sur, R. / Okawara, G. / Singh, G. et al. | 2005
- S150
-
P-136 Establishment and characterization of amylase-producing lung adenocarcinoma cell line, IMEC-2Yokouchi, H. / Yamazaki, K. / Shigemura, M. / Moriyama, T. / Konishi, J. / Takaoka, K. / Nishimura, M. et al. | 2005
- S152
-
P-143 Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancerZhou, C. / Su, B. / Zhao, Y. et al. | 2005
- S153
-
P-147 Assessment of pulmonary function tests in HOOKA(bubble-hubble) smokersAbedi, A. / Zarifi, M. / Sazavar, S. / Teimorzade, B. et al. | 2005
- S155
-
P-154 Diagnostic value of bronchoscopy and 99mTc-depreotidescintigraphy in selection of the candidates for lung cancer surgeryDudzevicius, V. / Mikalauskas, V. / Rubikas, R. / Sarauskas, V. / Sakalauskas, R. et al. | 2005
- S156
-
P-157 Development and validation of a clinical prediction rule for the diagnosis of lung cancer based in sex, age and serum tumor markersHernandez-Hernandez, J. / Martin-Casado, T. / Tapias del Pozo, J. / Sanchez-Marcos, J. / Rodriguez-Puebla, A. / Garrido-Garcia, B. / Navarro-Nieto, E. / Gomez del Campo, A. et al. | 2005
- S157
-
P-161 The value of simultaneous determination of neoplasmaticmarkers (CEA, Cyfra 21-1, TPA, NSE), sialic acid, mucoprotems and adenosine deaminase in pleural effusions to differentiate the neoplasmatic effusions from the benign onesKozielski, J. / Kamiń / ski, J. et al. | 2005
- S158
-
P-166 Targeting the therapy: Octreotide in thymoma relapseLongo, F. / Rosati, M. / Proietti, E. / Venuta, E. / Coloni, G. / Anile, M. / Scopinaro, F. / De Vincentis, G. / Vitolo, D. et al. | 2005
- S159
-
P-170 Sequential chemo-radio therapy with gemcitabine versus endoscopic electrocautery resection plus sequential chemo-radio therapy in patients with centraly placed non-small cell lung cancer (NSCLC)Mehić / B. / utić / H. / Dizdarević / Z. et al. | 2005
- S161
-
P-178 Ultrathin laser scanning bronchoscope and guidance system forthe peripheral lungSeibel, E. / Soper, T. / Johnston, R. / Glenny, R. et al. | 2005
- S162
-
P-182 Fluorescence bronchoscopy for selection of surgical procedurein patients with early staged endobronchial carcinomaTsunezuka, Y. / Oda, M. et al. | 2005
- S164
-
P-189 Trimodality therapy for mediastnoscopic N2-positive non-smallcell lung cancerAhn, Y. / Kang, M. / Nam, H. / Oh, D. / Park, Y. / Lim, D. / Park, K. / Shim, Y. / Kwon, O. et al. | 2005
- S165
-
P-193 Patiens with NSCLC and brain metastases benefits fromchemotherapy in a palliative settingBaekke, J. / Sindrup, H. / Olesen, R. / Palshof, T. / Rytter, C. / Hansen, O. et al. | 2005
- S166
-
P-197 Combined modality therapy in lung cancer patients with brain metastasisBudisin, E. / Canak, V. / Jovanović / S. / Budiš / in, N. / Niš / ević / V. et al. | 2005
- S167
-
P-201 Long term outcome of multimodality treatment of non small cell lung cancer (NSCLC) brain metastases: Experience of eight yearsCassano, A. / Pompucci, A. / D'Argento, E. / Schinzari, G. / Pozzo, C. / Basso, M. / Quirino, M. / Trigila, S. / Anile, C. / Barone, C. et al. | 2005
- S168
-
P-205 Treatment outcome of non-small cell lung cancer (NSCLC)-prognostic value of EGFR proteinE-Metnawi, W. / AbdelSalam, M. / El-Nahas, T. et al. | 2005
- S169
-
P-209 Concurrent biweekly gemcitabine plus cisplatin chemotherapyand radiotherapy in patients with locally advanced non-small cell lung cancerJung, M. / Kim, H. / Oak, C. / Jang, T. / Jeon, Y. / Jung, T. et al. | 2005
- S170
-
P-213 A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer; a non-platinum-based bimodality treatment scheduleLeong, S. / Fong, K. / Toh, C. / Lim, D. / Yap, S. / Tay, M. / Tan, E. et al. | 2005
- S171
-
P-217 Hypofractionated conformal chemoradiation for NSCLC in a UKcentreMartin, C. / Ajithkumar, T. et al. | 2005
- S173
-
P-224 A phase II study of concurrent chemoradiotherapy with navelbineand cisplatin for unresectable stage III NSCLCRusu, P. / Ciuleanu, T. / Cernea, D. / Pelau, D. / Gaal, V. / Cebotaru, C. / Guttman, T. / Todor, N. / Ghilezan, N. et al. | 2005
- S174
-
P-228 Software analysis of lung cancer clinical data and lung cancer tissue bank in HungarySzondy, K. / Podmaniczky, E. / Solya, Z. / Mueller, V. / Kiss, S. / Barta, P. et al. | 2005
- S176
-
P-237 Lung cancer detection in high risk patients with airflow obstruction; An ongoing studyBechtel, J. / Kelley, W. / Coons, T. / Mohler, P. / Mohler, A. / Klein, G. / Petty, T. et al. | 2005
- S177
-
P-241 A French pilot lung cancer screening trial randomizing multislice-spiral CT scan (MSCT) vs chest X-ray (CXR): Prevalence resultsBrechot, J. / Blanchon, T. / Lemarie, E. / Moro-Sibilot, D. / Milleron, B. / Grenier, P. / Flahault, A. et al. | 2005
- S178
-
P-245 245 Detection of RNA biomarkers in sputum of lung cancer patientsand high risk smokersFranklin, W. / Sugita, M. / Haney, J. / Miller, Y. / Keith, R. / Mitchell, J. / Hirsch, F. / Kennedy, T. / Bemis, L. et al. | 2005
- S179
-
P-249 Dante: A randomized study on lung cancer screening with spiral CT. Work in progressInfante, M. / Lutman, F. / Brambilla, G. / Cavuto, S. / Cariboni, U. / Destro, A. / Bianchi, P. / Alloisio, M. / Testori, A. / Incarbone, M. et al. | 2005
- S182
-
P-260 Combining genome wide (BAC array CGH and Serial analysis ofgene expression) and quantitative microscopy for the analysis of lung cancer and its pre-cursorsMacAulay, C. / Lonergan, K. / Garnis, C. / Coe, B. / Chi, B. / Guillaud, M. / Khojasteh, M. / LeRiche, J. / Lam, S. / Lam, W. et al. | 2005
- S183
-
P-265 Natural history of untreated endobronchial carcinoma in situMiller, Y. / Keith, R. / Hirsch, F. / Dempsey, E. / Franklin, W. / Kennedy, T. et al. | 2005
- S185
-
P-272 Dysplasia and aberrant DNA methyation profiles in risk and lungcancer patientsRosell, A. / Rodrí / guez, N. / Lloret, J. / Arellano, E. / Fernadez, M. / de la Torre, N. / Ramirez, J. / Gupta, J. / Taron, M. et al. | 2005
- S186
-
P-275 Island-lake model of carcinogenesis: Implications forrandomization, survival, and mortality in randomized trials of cancer screeningStrauss, G. / Babbitt, D. / Dominioni, L. et al. | 2005
- S188
-
P-282 Molecular profiling of lung nodules in a spiral CT-screening protocol shows multiple malignant featuresZudaire, M. / Pajares, M. / Lozano, M. / Agorreta, J. / Ezponda, T. / Bastarrika, G. / Torre, W. / Remirez, A. / Zulueta, J. / Montuenga, L. et al. | 2005
- S189
-
P-286 Safety, tolerability and efficacy of a therapeutic vaccine for nicotine dependenceCornuz, J. / Jungi, F. / Cerny, T. / Klingler, K. / Maurer, P. / Mueller, P. et al. | 2005
- S190
-
P-289 Comparison of DNA adduct levels in nasal mucosa lymphocytesand bronchial mucosa of cigarettes smokers and interaction with metabolic gene polymorhismsFelletti, R. / Verna, A. / Quaglia, A. / Neri, M. et al. | 2005
- S191
-
P-293 Primary lung cancer among women in north-western Himalayan region of India with special reference to Bidi smokingKashyap, S. / Negi, R. / Bansal, R. et al. | 2005
- S193
-
P-300 Genetic polymorphisms of N-acetyltransferase 2 (NAT2) andL-myc can evaluate lung cancer susceptibility by smokingOhsawa, Y. / Takahashi, J. / Inoue, N. / Takahata, C. / Yoshida, K. / Miyaishi, A. / Kasahara, M. / Kawashima, E. / Tabuchi, Y. / Tsubota, N. et al. | 2005
- S195
-
P-307 The epidemiology of tracheal, bronchial and lung cancerin CroatiaPolić / intin, M. / Tripković / I. / Kukulj, S. / Leppee, M. / ulig, J. et al. | 2005
- S197
-
P-313 How effectively can nicotine replacement therapy control the smoking habit?Takagi, K. / Kato, N. / Sasamoto, S. / Hata, Y. et al. | 2005
- S198
-
P-317 Differences between lung cancer patients using the internet andpatients in the clinicWei, S. / Hampshire, M. / Devine, P. / Metz, J. et al. | 2005
- S199
-
P-320 Gefitinib therapy of advanced non small-cell lung cancer (NSCLC): A Markov model-based economic analysisChouaid, C. / Monnet, I. / Robinet, G. / Perol, M. / Fournel, P. / Vergnenegre, A. et al. | 2005
- S200
-
P-324 Reporting on consistency of clinical practice with lung cancer guidelines: A clinical monograph by Cancer Care OntarioEvans, W. / Mackay, J. / Whitton, A. / Drossos, A. / Gregus, M. / Noyek, J. et al. | 2005
- S201
-
P-327 Can performance status (PS) be determined accurately bypatients? Results of a prospective trial evaluating ECOG and Karnofsky PS as well as patient-rated PS in non-small cell lung cancer (NSCLC)Gralla, R. / Hollen, P. / Kuruvilla, P. / Meharchand, J. / Solow, H. / Leighl, N. / Chin, C. / Stewart, J. et al. | 2005
- S202
-
P-330 The longitudinal effect of exercise training on pulmonary function and related factors in patients receiving lung resectionLee, S. / Wang, K. / Chang, N. et al. | 2005
- S205
-
P-341 The Cochrane Lung Cancer Review Group. An evidence-based resource for the management of lung cancerTort, S. / Macbeth, F. / Roque, M. / Garcia, J. / Bonfill, X. et al. | 2005
- S206
-
P-345 Outcome of advanced non-small cell lung cancer patients treatedin a single institution with first generation platinum doublets. Using a retrospective analysis to help decisions in resource allocationZukin, M. / Ferreira, C. / Hermont, P. / Dienstmann, R. / Cunha, G. / Rodrigues, A. / Boukai, A. / Araujo, R. / Beserra, L. / Andrade, C. et al. | 2005
- S207
-
P-349 The role of somatostatin-receptor-scintigraphy with 99m-Tc-depreotide(NeoSpect) in the diagnosis of lung cancerBå / th, M. / Kö / lbeck, K. / Forslö / w, U. / Danielsson, R. et al. | 2005
- S209
-
P-358 Value of integrated PET-CT versus CT and PET alone in thedetection of lung metastases in patients with a known primary tumor: A retrospective studyDe Wever, W. / Meylaerts, L. / De Ceuninck, L. / Verschakelen, J. et al. | 2005
- S210
-
P-362 CT-scan diagnosis of enlarged mediastinal lymph nodes does not predict N2- or N3-disease in patients with non-small-cell bronchial carcinoma (NSCLC)Fieguth, H. / Simon, A. / Wiedenmann, D. / Kamand, A. / Vogl, T. et al. | 2005
- S211
-
P-365 Imaging findings of paraneoplastic syndromes that preceded the diagnosis of bronchogenic carcinomaGoldner, B. / Dodic, M. / Paunovic, D. / Djordjevic, R. et al. | 2005
- S212
-
P-371 EBUS-TBNA in non diagnosed lesions in the mediastinum or the hillar regions of the lungKrasnik, M. / Herth, F. / Vilmann, P. / Eberhardt, R. / Guldhammer Skov, B. et al. | 2005
- S213
-
P-376 Prognosis of lung carcinoma patients with intraoperative positivepleural lavage cytologyNakahara, R. / Matsuguma, H. / Kondo, T. / Kamiyama, Y. / Igarashi, S. / Mori, K. / Yokoi, K. / Kodama, T. / Miyazawa, N. et al. | 2005
- S214
-
P-380 CT-guided percutaneous fine needle aspiration biopsy ofsubcentimeter intrapulmonary nodulesPatsios, D. / Roberts, H. / Paul, N. / Chung, T. / Herman, S. / Weisbrod, G. et al. | 2005
- S215
-
P-384 Multislice CT and SPECT-CT: Correlation in diagnosis ofpulmonary nodulesSergiacomi, G. / Leporace, M. / Carlani, M. / Laviani, F. / Di Costanzo, G. / Schillaci, O. / Simonetti, G. et al. | 2005
- S216
-
P-387 Fluorescence diagnosis for mediastinal lymph node metastasis of lung cancerTakizawa, H. / Kondo, K. / Fujino, H. / Kenzaki, K. / Miyoshi, T. / Sakiyama, S. / Tangoku, A. et al. | 2005
- S217
-
P-391 How dedicated Positron Emission Tomography-CT (PET-CT) affects the diagnostic and therapeutic approaches to patients managed by a Multimodality Thoracic Oncology GroupYung, R. / Gramatikova, A. / Brock, M. / Brahmer, J. / Ettinger, D. / Friedman, K. / Jacene, H. / Colvin, L. / Lang, P. / Yang, S. et al. | 2005
- S218
-
P-393 Treatment related quality of life findings in patients withmalignant pleural mesothelioma: An international randomized Phase III study of cisplatin with or without raltitrexedBottomley, A. / Gaafar, R. / Manegold, C. / Burgers, S. / Coens, C. / Legrand, C. / Vincent, M. / Giaccone, G. / van Meerbeeck, J. et al. | 2005
- S219
-
P-397 Response of malignant pleural mesothelioma to chemotherapy does not confer a survival advantageFennell, D. / Steele, J. / Sheaff, M. / Evans, M. / Shamash, J. / Wells, P. / Rudd, R. et al. | 2005
- S220
-
P-401 Evaluating improvement in patient-reported dyspnea and pulmonary function tests (PFTs) in patients with malignant pleural mesothelioma (MPM): An analysis as part of the 448-patient randomized pemetrexed + cisplatin versus cisplatin trialGralla, R. / Symanowski, J. / Boyer, M. / Paoletti, P. / Rusthoven, J. / Manegold, C. / Lianes, P. / Liepa, A. / Vogelzang, N. et al. | 2005
- S221
-
P-404 Does transforming growth factor-beta1 codon 25 polymorphismgenotype influence tumour histology or patient survival in malignant pleural mesothelioma?King, J. / Sinnott, P. / Swindell, R. / Pickering, C. / Thatcher, N. / Hasleton, P. et al. | 2005
- S222
-
P-408 Immunohistochemical panels for distinguishing betweenmalignant mesothelioma and pulmonary adenocarcinomaKushitani, K. / Takeshima, Y. / Inai, K. et al. | 2005
- S223
-
P-411 High dose methotrexate (MTX) and interferons (IF) in malignant mesothelioma. A Scandinavian phase I studyLenneby, C. / Karin, M. / Ursula, F. / Carl-Johan, L. / Gunnar, H. / Ola, B. et al. | 2005
- S224
-
P-414 18F-FDG-PET in mesothelioma: Is there a prognostic value?Michetti, G. / Guerra, U. / Virotta, G. / Colombo, R. / Quadri, A. / Pessi, A. / Ori Belomette, M. / LaBianca, R. et al. | 2005
- S225
-
P-419 A randomised controlled trial of radiotherapy to mesotheliomadrain sitesO'Rourke, N. / Curto Garcia, J. / McMenemin, R. / Hill, J. / Lawless, C. et al. | 2005
- S227
-
P-426 Multimodal therapy in 328 patients with malignant pleuralmesotheliomaSerke, M. / Kaiser, D. / Fisseler-Eckhoff, A. / Mairinger, T. / Loddenkemper, R. et al. | 2005
- S228
-
P-429 Living well with mesothelioma-an alternative approachStafford, J. et al. | 2005
- S229
-
P-432 Vinflunine (VFL) in first line treatment of malignant pleuralmesothelioma (MPM): Final results of a phase II studyTalbot, D. / Margery, J. / Dabouis, G. / Dark, G. / Taylor, H. / Macha, H. / Pinel, M. / Betton, A. / Riviere, A. / Ruffie, J. et al. | 2005
- S230
-
P-435 Long-term survival update from the randomized phase III study of pemetrexed plus cisplatin vs cisplatin in patients with malignant pleural mesothelioma (MPM)Vogelzang, N. / Symanowski, J. / Rusthoven, J. / Manegold, C. / Boyer, M. / Nguyen, B. / Paoletti, P. et al. | 2005
- S231
-
P-438 A retrospective analysis of prognostic factors and rreatment outcomes of different chemotherapy regimens in patients with locally advanced (Stage IIIB) and metastatic (Stage IV) non-small cell lung cancer (NSCLC): A single Egyptian institution's experienceAzim, H. A. / Moneim, D. A. / Kamal, N. / Raouf, M. / Kamel, Y. M. et al. | 2005
- S232
-
P-442 Erlotinib for good prognosis patients with untreated, advanced stage NSCLCAkerley, W. / Maul, S. / Majer, M. / Fitzpatrick, F. et al. | 2005
- S233
-
P-447 Treatment of non-small-cell lung cancer with gefitinib (IRESSA)in a compassionate-use program: The Portuguese experienceAraujo, A. / Teixeira, M. / Figueiredo, A. / Correia, J. / Melo, M. / Parente, B. / Bernardo, M. / Queiroga, H. / Barata, F. et al. | 2005
- S234
-
P-450 Gemcitabine-epidoxorubicin-cisplatin (GEP) as a new tripletcombination chemotherapy in patients with stage IIIB-IV non small cell lung cancer (NSCLC). A dose finding studyBarni, S. / Pronzato, P. / Cazzaniga, M. / Vigani, A. / Frontini, L. / Di Costanzo, F. et al. | 2005
- S235
-
P-454 Phase I/II trial of carboplatin (CBDCA)/weekly paclitaxel in patients with advanced non-small cell lung cancer in Japanese population: WJTOG 9907Bessho, A. / Saka, H. / Kitaguchi, S. / Yamamoto, M. / Shinkai, T. / Fukuoka, M. / Ariyoshi, Y. et al. | 2005
- S236
-
P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trialBinder, D. / Schweisfurth, H. / Grah, C. / Schä / per, C. / Temmesfeld-Wollbrü / ck, B. / Siebert, G. / Suttorp, N. / Beinert, T. et al. | 2005
- S237
-
P-461 Modified weekly schedule of cisplatin-vinorelbine chemotherapy in stages IIIB-IV non small cell lung cancer (NSCLC). Preliminary results about 18 patientsBoussem, H. / Benna, F. / Bourguiba, M. / Hamzaoui, A. / Kilani, T. / Lagha, M. / Megdiche, M. / Gasmi, J. et al. | 2005
- S238
-
P-464 Oxaliplatin and gemcitabine in advanced NSCLC: A multicentre phase 2 Australian studyBroad, A. / Links, M. / Rosenthal, M. / Abraham, R. / Clarke, S. / Burns, I. / Dilulio, J. / Mitchell, P. et al. | 2005
- S240
-
P-472 Continuous-infusion paclitaxel and weekly cisplatin with concurrent radiation therapy for locally advanced non-small cell lung cancerCho, E. / Jeong, S. / Ahn, C. / Lee, S. / Park, J. / Kyung, S. / Lee, K. / Park, S. / Bang, S. / Shin, D. et al. | 2005
- S241
-
P-476 Phase II study of gemcitabine plus oxaliplatin as first-line treatment in elderly or unfit patients with advanced non-small cell lung cancer (NSCLC). AcrossDomè / nech, M. / Losa, F. / Blanco, R. / Nogué / M. / Montesinos, J. / Mesí / a, C. / Gallardo, E. et al. | 2005
- S242
-
P-480 A comparative study of combination chemotherapy with docetaxell cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancerEl-Nashar, E. et al. | 2005
- S243
-
P-484 CCND1/Cyclin D1 A870G gene polymorphism is associated with non-small cell lung cancer (NSCLC) risk, and affects prognosis and response to chemotherapyGautschi, O. / Huegli, B. / Ziegler, A. / Bigosch, C. / Ratschiller, D. / Bowers, N. / Stahel, R. / Heighway, J. / Betticher, D. et al. | 2005
- S244
-
P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapyGridelli, C. / Reck, M. / Gregorc, V. / Migliorino, M. / Muller, T. / Manegold, C. / Favaretto, A. / Schmittel, A. / Caffo, O. / Blatter, J. et al. | 2005
- S245
-
P-491 Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)Guerreroero Zotano, A. / Pellin Ariñ / o, L. / Molina Saera, J. / Palomar Abad, L. / Ponce Lorenzo, J. / Gimé / nez Ortiz, A. / Dí / az Beveridge, R. et al. | 2005
- S246
-
P-094 Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancerHasturk, S. / Hatabay, N. / Ece, F. / Karatas, M. / Hanta, I. et al. | 2005
- S247
-
P-499 Prognostic relevance of 60 clinical factors, “classical” laboratoryparameters and tumor markers in patients with advanced non-small cell lung cancerHoldenrieder, S. / von Pawel, J. / Raith, H. / Feldmann, K. / Stenman, U. / Nagel, D. / Stieber, P. et al. | 2005
- S248
-
P-503 Smoking history, and serum NSE level as prognostic factors inthe adenocarcinoma of lung cancer patientsJang, T. / Kim, H. / Ok, C. / Ryu, J. / Jung, M. et al. | 2005
- S249
-
P-507 Randomized trial to investigate the impact of a computer-generated quality of Life assessment program on treatment patterns for advanced non-small cell lung cancer patientsKassam, F. / Salvarrey, A. / Shepherd, F. / Feld, R. / Gralla, R. / Leighl, N. et al. | 2005
- S250
-
P-509 First line treatment with docetaxel and cisplatin in non-small celllung cancer patients: A retrospective analysisKentepozidis, N. / Agelaki, S. / Vamvakas, L. / Kotsakis, A. / Saridaki, Z. / Gioulbasakis, J. / Kalykaki, A. / Ignatiadis, M. / Sfakiotaki, G. / Mavroudis, D. et al. | 2005
- S251
-
P-512 Preliminary results of the prospective randomized phase III trialof KROG 03-02 on the induction chemotherapy in the concurrent chemoradiotherapy for the locally advanced non-small cell lung cancerKim, S. / Choi, E. / Kim, J. / Lee, S. / Suh, C. / Lee, J. / Ha, S. / Park, C. / Cho, K. et al. | 2005
- S252
-
P-516 Lymphokine-activated killers' immunotherapy of pleural effusionKiselevsky, M. / Shubina, I. / Volkov, S. et al. | 2005
- S255
-
P-526 Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)Leighl, N. / Laurie, S. / Knox, J. / Ellis, P. / Shepherd, F. / Burkes, R. / Pond, G. / Zwiebel, J. / Moore, M. et al. | 2005
- S256
-
P-530 Topoisomerase inhibitors: Combination of innotecan and epirubicin is feasible as salvage therapy for heavily pre-treated advanced lung cancer patientsMalik, S. / Min, F. / Hwang, J. / Marshall, J. et al. | 2005
- S257
-
P-533 Single agent weekly paclitaxel chemotherapy in elderly or frailnon-small cell lung cancer (NSCLC) patients: Final results of a phase II trial Spanish Lung Cancer Group (GECP 00/02)Massuti, B. / Camps, C. / Garrido, P. / Viñ / olas, N. / Barcelo, J. / Barneto, I. / Guillot, M. / Jimé / nez, M. et al. | 2005
- S258
-
P-537 A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancerMoore, T. / Patel, T. / Segal, M. / Thompson, J. / Zangmeister, J. / Larrimer, N. / Merriman, N. / Chidiac, T. et al. | 2005
- S259
-
P-541 A phase I study of pemetrexed supplemented with folic acid (FA)and vitamin B12 (VB12) in Japanese patients with solid tumorsNegoro, S. / Nakagawa, K. / Kudoh, S. / Matsui, K. / Yamamoto, N. / Latz, J. / Adachi, S. / Fukuoka, M. et al. | 2005
- S260
-
P-544 Results of lung cancer patients with carcinomatous pleuritis who underwent limited operations combined with parietal pleurectomyOhta, Y. / Tamura, M. / Matsumoto, I. / Watanabe, G. et al. | 2005
- S261
-
P-548 A multicenter phase II study of docetaxel/gemcitabine weekly inadvanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): Preliminary results of the 02-02 Groupe Français de Pneumo-Cancérologie (GFPC) studyLe Caer, H. / Gimenez, C. / Chouaid, C. / Jullian, H. / Le Treut, J. / Bombaron, P. / Geriniere, L. / Hominal, S. / Dominique, P. / Auliac, J. et al. | 2005
- S262
-
P-551 Single-agent navelbine oral (NVBo) as chemotherapy (CT) in elderly patients (pts) with advanced stage or metastatic non-small cell lung cancer (NSCLC)Parente, B. / Queiroga, H. / Espanhol, V. / Cunha, J. / Fernandes, A. / Barroso, A. / Conde, S. et al. | 2005
- S264
-
P-558 Clinical factors that Influence the hazard of death In advanced non-small cell lung cancer NSCLC patients treated with platinum-based chemotherapy: Analysis of Individual patient data from prospective trials In monocentric settingRadosavljevic, D. / Kezic, I. / Jelic, S. / Gavrilovic, D. / Tomasevic, Z. et al. | 2005
- S266
-
P-565 A Phase II study of KOS-862 (Epothilone D) as second-linetherapy in non-small cell lung cancerRizvi, N. / Villalona-Calero, M. / Lynch, T. / Yee, L. / Gabrail, N. / Sandler, A. / Cropp, G. / Graham, M. / Palmer, G. et al. | 2005
- S267
-
P-569 Efficacy and survival benefit of prophylactic Shakuyaku-Kanzou-Tofor myalgia/arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancerSawa, T. / Yoshida, T. / Ishiguro, T. / Mimori, T. / Sawada, M. / Ohno, Y. / Fujiwara, H. et al. | 2005
- S268
-
P-572 Phase I–II trial of TLK286 (telcyta), carboplatin (C), and paclitaxel(P) as first-line treatment for advanced non-small cell lung cancer (NSCLC)Seguist, L. / Fidias, P. / Temel, J. / Kennedy, E. / Ostler, P. / Rabin, M. / Huberman, M. / Keck, J. / Brown, G. / Lynch, T. et al. | 2005
- S269
-
P-575 Preclinical and preliminary phase I trial results of motexafin gadolinium (MGd) with docetaxel & cisplatin in non-small cell lung cancer (NSCLC)Stewart, D. / Oh, Y. / Schaerer, R. / Naumobski, L. / Phan, S. et al. | 2005
- S270
-
P-579 Meloxicam in combination with paclitaxel and carboplatin inpatients with advanced non-small cell lung cancerTakahashi, T. / Ueda, S. / Kogure, Y. / Ebisawa, M. / Asai, G. / Yamamoto, N. et al. | 2005
- S271
-
P-583 Clinical parameters predictive of response in advance non-small-cell lung cancer (NSCLC) patients receiving gefitinib in am expanded access program (EAP) after failure of chemotherapyTibaldi, C. / Vasile, E. / Chella, A. / Russo, E. / Bernardini, I. / Nacci, A. / Falcone, A. et al. | 2005
- S272
-
P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)van Puijenbroek, R. / Bosqué / e, L. / Tits, G. / Germonpre, P. / Strobbe, E. / Vansteenkiste, J. et al. | 2005
- S274
-
P-594 Extended survival in stage IV patients treated with low dose maintained chemotherapyYamaguchi, N. / Rangel-Pestana, D. / Vargas, F. / Araujo, M. / Donatangelo, S. / Marini, A. / Naves, A. / Souza, A. / Cordeiro, I. / Bevilacqua, R. et al. | 2005
- S275
-
P-598 Oxaliplatin plus vinorelbine in advanced non-small cell lung cancerZhou, C. / Zhang, J. / Xu, Y. / Xu, J. / Lu, M. / Wang, L. et al. | 2005
- S276
-
P-601 High dose radiation therapy with 3 Gy per fraction in medicallyinoperable high dose radiation therapy with 3 Gy per fraction in medically inoperable stage I/II non-small cell lung cancerAhn, Y. / Kim, B. / Lim, D. / Nam, H. / Oh, D. / Park, Y. et al. | 2005
- S277
-
P-605 Symptom relief and quality of life (COL) in PS2 patients withnon-small cell lung cancer (NSCLC) subsequent to treatment with paclitaxel poliglumex (XYOTAXT™): Phase 3 trial resultsCella, D. / Cashy, J. et al. | 2005
- S278
-
P-608 Prognostic factors in resected stage I non small cell lung carcinoma (NSCLC): Multivariate analysis of 565 casesDujon, A. / Thiberville, L. / Martinod, E. / Saintighy, P. / Morero, J. / Azorin, J. et al. | 2005
- S279
-
P-613 Cytoplasmic expression of Cyclin D1 correlates with tumorrecurrence and mortality in stage I NSCLCGajra, A. / Vajpayee, N. / Wade, M. / El-Zamar, O. / Dexter, E. / Kohman, L. / Gamble, G. / Graziano, S. et al. | 2005
- S280
-
P-616 Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancerGiordano, K. / Jatoi, A. / Adjei, A. / Creagan, E. / Croghan, G. / Jett, J. / Marks, R. / Molina, J. / Okuno, S. / Richardson, R. et al. | 2005
- S285
-
P-636 Impact of comorbidity on survival in untreated stage I and IInon-small cell lung cancer: A retrospective analysisSahmoun, A. / Chadha, A. et al. | 2005
- S286
-
P-640 Surgery therapy in elderly patients with NSCLCUcvet, A. / Yuncu, G. / Sevinc, S. / Ceylan, K. / Yaldý / z, S. / Unsal, S. / Ozsinan, F. / Kul, C. et al. | 2005
- S288
-
P-648 EGFR and Ki-ras mutations in pulmonary adenosquamous carcinomaAoe, M. / Toyooka, S. / Yatabe, Y. / Tokumo, M. / Ichimura, K. / Tomii, K. / Date, H. / Mitsudomi, T. / Shimizu, N. et al. | 2005
- S289
-
P-651 Combined use of bronchial lavages and brushings in diagnosis and typing of central lung tumorsBurkadze, G. / Turashvili, G. / Vacharadze, K. et al. | 2005
- S290
-
P-655 Co-expression of p21WAF1/CIP1, p53, pRb, mdm2 and cyclin D1in NSCLC cellsDworakowska, D. / Jassem, E. / Jassem, J. / Wiedorn, K. / Boltze, C. / Dworakowski, R. / Lapinski, M. / Tomaszewski, D. / Jaskiewucz, K. / Czestochowska, E. et al. | 2005
- S292
-
P-664 Visceral pleural invasion and biohistological activity in resected non-small cell lung cancerLuu, T. / Miller, D. / Force, S. / Miller, J. et al. | 2005
- S293
-
P-669 Immunohistochemical differential diagnosis between large cellneuroendocrine and small cell carcinoma by tissue microarray analysisNitadori, J. / Ishii, G. / Tsuta, K. / Yokose, T. / Murata, Y. / Yoshida, J. / Nagai, K. / Ochiai, A. et al. | 2005
- S295
-
P-675 Clinical importance to distinction of B3 thymoma from othertumor types in the WHO histological classification of thymomaSonobe, S. / Miyamoto, H. / Izumi, H. / Sakao, Y. / Futagawa, T. / Anami, Y. / Yamazaki, A. / Oh, T. / Fukai, R. / Saito, Y. et al. | 2005
- S296
-
P-678 Use of automated image cytometry in diagnosis of lung cancer from bronchial washingsTercelj, M. / Jerse, M. / Gavanski, G. / Doudkine, A. et al. | 2005
- S297
-
P-682 Development of transplantable tumor lines from a variety ofhuman lung cancers via sub-renal capsule graftingWang, Y. / Cutz, J. / Guan, J. / English, J. / Xue, H. / Leriche, J. / Squire, J. / Sutcliffe, M. / Gout, P. / Lam, S. et al. | 2005
- S299
-
P-689 The significance of ERβ expression in surgically treated non-small-cell lung cancersYung-Chie, L. et al. | 2005
- S300
-
P-693 Three little words: Awareness, support and education. Thedevelopment of Lung Cancer CanadaBurnett, J. / Winterhoff, M. et al. | 2005
- S301
-
P-696 Strategies employed by patients to cope with the stress of a rapid access lung cancer clinicHuqhes, J. / McIver, A. / Stitt, N. / Ledson, M. / Smyth, C. et al. | 2005
- S302
-
P-700 Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis in patients with non-small cell lung cancer: A prospective studyArpin, D. / Perol, D. / Blay, J. / Falchero, L. / Claude, L. / Vuillermoz-Blas, S. / Martel-Lafay, I. / Cottin, V. / Carrie, C. et al. | 2005
- S303
-
P-703 Fused PET/CT images for planning radical radiotherapy (RRT) fornon-small cell lung cancer (NSCLC)Bayne, M. / Everitt, S. / Yuen, K. / Pitman, A. / Lau, E. / Hicks, R. / Ball, D. / MacManus, M. et al. | 2005
- S304
-
P-707 Preliminary analysis of local radiation therapy technique fornon-small cell lung cancerChin, H. / Paull, D. / Nguyen, T. / Crowell, R. et al. | 2005
- S305
-
P-711 CyberKnife® frameless image-guided radiosurgery with the Synchrony™ motion tracking module in the definitive treatment of small peripheral lung tumors: The Georgetown University Hospital early experienceCollins, B. / Malik, S. / Margolis, M. / Marshall, M. / Jamis-Dow, C. / Dieterich, S. / Lundsten, M. / McRae, D. / Reichner, C. / Anderson, E. et al. | 2005
- S306
-
P-715 Hypofractionated radiation therapy (HRT) alone as the curative treatment for patients with early stage, medically inoperable non-small cell lung cancer (NSCLC)Faria, S. / Souhami, L. / Dulcos, M. / Portelance, L. / Guerra, J. / Gruber, J. / Hirsh, V. et al. | 2005
- S307
-
P-719 3D conformal single high-dose boost radiosurgery(SRS) forperipheral stage I non-small cell lung cancer(NSCLC) using C-Arm linear accelerator and a spiro-analyzerHayakawa, K. / Niibe, Y. / Kitano, M. / Ishiyama, H. / Uemae, M. / Masuda, N. / Yoshimura, H. et al. | 2005
- S310
-
P-731 Radiation pneumonitis in patients with non-small cell lung cancer: A review of risk prediction and reductionMehta, V. et al. | 2005
- S311
-
P-734 Palliative radiotherapy for patient with advanced non small cell lung cancerMolinaro, M. et al. | 2005
- S312
-
P-738 Clinical application of simplified intensity modulated radiation therapy (SIMAT) in recurrent NSCLCRodrigues, G. / Wong, E. / Erickson, A. / Yoon, F. / Sexton, T. et al. | 2005
- S313
-
P-741 Reduction of observer variation by matched CT-PET for lung cancer delineationSteenbakkers, R. / Duppen, J. / Fitton, I. / Deurloo, K. / Zijp, L. / Belderbos, J. / de Jaeger, K. / Nowak, P. / van Herk, M. / Rasch, C. et al. | 2005
- S314
-
P-744 Dosimetric gains from respiration-gated radiotherapy for stage III lung cancer: An analysis of 4DCT dataUnderberg, R. / van Sö / rnsen de Koste, J. / Slotman, B. / Senan, S. et al. | 2005
- S315
-
P-748 Accelerated high-dose radiotherapy by target splitting for inoperable NSCLC: A phase I trialWurstbauer, K. / Deutschmann, H. / Kopp, P. / Merz, F. / Nairz, O. / Studnicka, M. / Sedlmayer, F. et al. | 2005
- S316
-
P-752 Biomarkers for small cell lung cancer (SCLC): DNA methylationand GD2 synthase transcript levelsChen, L. / Krug, L. / Azzoli, C. / Cheung, I. / Park, S. / Danenberg, P. / Danenberg, K. / Cheung, N. / Kris, M. et al. | 2005
- S317
-
P-756 Third-line chemotherapy for small cell lung cancer (SCLC)de Jong, W. / ten Hacken, N. / Groen, H. et al. | 2005
- S318
-
P-760 Utility of second-line chemotherapy for relapsed extensive small cell lung cancer (E-SCLC) in clinical practice: Who benefits?Froeschl, S. / Laurie, S. / Gallant, V. et al. | 2005
- S320
-
P-767 Is the total dose of importance in thoracic radiotherapy ofsmall-cell lung cancer (SCLC) limited disease (LD)?Hallqvist, A. / Nyman, J. / Rylander, H. et al. | 2005
- S321
-
P-771 Surgical treatment of small cell lung cancer during 1980–2003yearsJackevicius, A. / Cicenas, S. / Aleknavicius, E. / Ciceniene, A. et al. | 2005
- S322
-
P-775 A 3-week schedule of cisplatin and irinotecan combinations chemotherapy for the previously untreated small-cell lung cancer: Phase II studyKim, S. / Kim, J. / Jung, S. / Ahn, J. / Cho, M. / Yoon, W. / Kwon, S. / Kang, H. et al. | 2005
- S323
-
P-779 Impact of anemia on outcomes of therapy in limited small celllung cancer (L-SCLC): An analysis of studies performed by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)Laurie, S. / Ding, K. / Whitehead, M. / Feld, R. / Murray, N. / Seymour, L. / Shepherd, E. et al. | 2005
- S326
-
P-788 The snake venom toxin taipoxin confers specific toxicity to smallcell lung cancer cell linesPoulsen, T. / Pedersen, N. / Pedersen, M. / Poulsen, H. et al. | 2005
- S328
-
P-796 A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)Socinski, M. / Weissman, C. / Hart, L. / Beck, J. / Choksi, J. / Hanson, J. / Prager, D. / Bloss, L. / Ye, Z. / Obasaju, C. et al. | 2005
- S329
-
P-801 Pleurodesis induction with powder collagen at malignant pleuraleffusionAkopov, A. / Egorov, V. / Varlamov, V. et al. | 2005
- S330
-
P-805 Lung Cancer in Wales — The development of a National ForumBaker, J. / Tapper, G. / Wilson, A. et al. | 2005
- S331
-
P-808 Concurrent medications as potential modifiers of radiation pneumonitis in lung cancer patientsBezjak, A. / Soyfer, V. / Yi, Q. / Sun, A. / Kane, G. / Waldron, J. / Cho, J. / Wells, W. / Payne, D. et al. | 2005
- S332
-
P-812 Hemoglobin levels and quality of life (QoL) in subjects with solid tumors receiving chemotherapy and epoetin alfa 40K (40,000 IU) once weekly: Focus on lung cancer patientsCartenì / G. / Giannetta, L. / Ucci, G. / De Signoribus, G. / Vecchione, A. / Pinotti, G. / Orecchia, S. et al. | 2005
- S333
-
P-814 Symptom clusters and pain in advanced lung cancerDavis, M. / Walsh, D. / Kirkova, J. / LeGrand, S. / Lagman, R. / Rybicki, L. et al. | 2005
- S334
-
P-818 Utilising evidence in a multidisciplinary setting to optimisepatient careEveritt, S. / Krishnasamy, M. / Duffy, M. / Klapper, R. / Ball, D. / Love, K. et al. | 2005
- S335
-
P-821 Off the chart healingGallagher, C. / Hundleby, M. / Szwajkowski, C. / Gilker, N. et al. | 2005
- S336
-
P-824 Transdermal fentanyl enhance the improvement of cancer pain in advanced NSCLC patients in TaiwanHo, M. et al. | 2005
- S337
-
P-828 Collaborative working between a lung nurse and Palliative care teamKelly, J. / Rudrum, I. / Preston, M. / Chapman, C. et al. | 2005
- S338
-
P-832 Chinese herbal medicine (CHM) induces immuno-modulation in patients with advanced stage non-small lung cancer (NSCLC): A double-blind placebo-control randomized studyMok, T. / Wong, C. / Lam, K. / Chan, L. / Pan, Z. / Au, W. / Xu, M. / Chan, A. / Chak, K. / Zee, B. et al. | 2005
- S339
-
P-837 Lung cancer and the family: Couples' management strategies in facing terminal illnessPicco, C. / Thirlwell, S. / Ezer, H. et al. | 2005
- S340
-
P-840 Epoetin beta 30,000 IU once weekly for the treatment ofanaemia in patients with lung cancer receiving chemotherapy: A prospective survey of the efficacy and timing of treatment in a clinical settingPirker, R. / Lehnert, M. / Minar, W. et al. | 2005
- S341
-
P-844 Improving communication: A study to evaluate the use of e-mail communication between Nurse Specialists and patients with lung cancer and their carersSherwin, A. / Moore, S. / Plant, H. et al. | 2005
- S342
-
P-848 Prevention of chemotherapy-induced febrile neutropenia (FN) by the addition of granulocyte-colony stimulating factor (G-CSF) to antibiotics in small cell lung cancer (SCLC) patients at risk of FN: A prospective economic evaluation along a Dutch randomised phase III trialTimmer-Bonte, J. / Adang, E. / de Boo, T. / Tjan-Heijnen, V. et al. | 2005
- S343
-
P-851 Quality of life and anxiety-depression in lung cancer patients:Preliminary results of a French multi-professional interview for diagnosis disclosure (MIDD)Vernejoux, J. / Grandon, L. / Izadifar, A. / Decouvelaere, A. / Josse, M. / Prevot, S. / Taytard, A. et al. | 2005
- S345
-
P-858 Sleeve lobectomy versus pneumonectomy: Tumor characteristics and comparative analysis of feasibility and results: The case of right upper lobe cancerBagan, P. / Berna, P. / Badia, A. / Le Pimpec Barthes, F. / Souilamas, R. / Dujon, A. / Riquet, M. et al. | 2005
- S346
-
P-862 Treatment of neuroendoctrine tumors: Our experienceCamplese, P. / Mucilli, F. / Iarussi, T. / Cipollone, G. / Pardolesi, A. / Sacco, R. et al. | 2005
- S347
-
P-866 Title: Total lung conservation surgery in main bronchial resectable lesions of low invasive potentialDeshpande, R. / Sharma, S. / Khithani, A. et al. | 2005
- S348
-
P-870 When to perform a mediastinoscopy in the staging of lung cancer?Fibla, J. / Simon, C. / Perez, J. / Molins, L. et al. | 2005
- S349
-
P-874 Clinical significance of surgical resection for recurrent non-smallcell lung cancerHishida, T. / Nagai, K. / Yoshida, J. / Ishii, G. / Nishimura, M. / Nishiwaki, Y. / Saijo, N. et al. | 2005
- S350
-
P-878 Retroperitoneal and intrathoracic paraspinal malognant peripheral nerve sheath tumor: A case reportHsieh, M. / Liu, Y. / Wu, Y. / Lu, M. / Liu, H. et al. | 2005
- S352
-
P-885 Accuracy and its affecting factors of prediction of functional reserves after lung cancer surgeryJang, S. / Lee, J. / Yoo, J. / Eom, K. / Kim, D. / Jeong, H. / Jung, K. et al. | 2005
- S353
-
P-890 Thoracic cavity management with C3F8 gas after pneumonectomyKimura, S. et al. | 2005
- S354
-
P-895 Modified muscle sparing mini-thoracotomy as a standard approach for resection of NSCLCLiu, C. et al. | 2005
- S356
-
P-903 Quantified pathologic response predicts survival and relapse after chemotherapy followed by surgery in non small cell lung cancer (nsclc)Muguruza, I. / Fogue, L. / Ganido, P. / Muñ / oz-Molina, G. / Cabañ / ero, A. / Mier-Odriozola, J. / Saldañ / a, D. et al. | 2005
- S358
-
P-911 Preoperative serum erythropoietin concentration as an outcomepredictor in patients following surgery for non small cell lung cancerPaul, I. / Lappin, T. / Graham, A. et al. | 2005
- S359
-
P-915 Surgical theraphy by using tracheal sleeve pnomonectomy of a carcinoid tumor complicating a total atrioventricular block with a carinal localisationSanli, A. / Onen, A. / Karacam, V. / Gokcen, B. / Kargý / A. / Acý / kel, U. et al. | 2005
- S361
-
P-924 Clinical impact of pre-treatment haemoglobin (HGB) level, whiteblood cell (WBC) and platelet (PLT) counts: Updated multivariate survival analysis of 639 operable non-small cell lung cancer (NSCLC) patientsSzostakiewicz, B. / Plichta, x. / Murawski, M. / Rzyman, W. / Dziadzuszko, R. / Jassem, J. et al. | 2005
- S362
-
P-928 Nutritional status affects survival after lobectomy for lung cancerTewari, N. / Martin-Ucar, A. / Beggs, L. / Morgan, E. / Beggs, D. / Duffy, J. et al. | 2005
- S363
-
P-932 False positives of an intensive postoperative follow-up fornon-small cell lung cancer (NSCLC)Westeel, V. / Olaru, I. / Falcoz, P. / Ardizzoni, A. / Choma, D. / Dubiez, A. / Jacoulet, P. / Pugin, J. / Dalphin, J. / Depierre, A. et al. | 2005
- S365
-
P-939 XYOTAX™ (paclitaxel poliglumex, PPX): Pharmacokineticevidence for prolonged tumor exposure and reduced systemic exposure to paclitaxelBernareggi, A. / Oldham, F. / Baker, B. / Besman, M. / Singer, J. et al. | 2005
- S366
-
P-940 A novel methodology for the identification of lung cancertherapeutic targets via meta-analysis of gene expression microarraysBhandari, M. / Kalemkerian, G. / Chinnaiyan, A. et al. | 2005
- S367
-
P-943 Effect of inducible Fhit and p53 expression in Calu-1 lung cancercell lineCavazzoni, A. / Galetti, M. / Petronini, P. / Fumarola, C. / Alfieri, R. / Rusca, M. / Bobbio, A. / Carbognani, P. et al. | 2005
- S368
-
P-947 The role of circulating endothelial progenitor cells in non-smallcell lung cancerDome, B. / Timar, J. / Ostoros, G. / Meszaros, L. / Dobos, J. / Raso, E. / Renyi-Vamos, E. / Bogos, J. / Agocs, L. / Tovari, J. et al. | 2005
- S371
-
P-957 The direct antitumor effect of bisphosphonates on non-smalllung cancer In vitroKoshimune, R. / Ohtani, Y. / Hara, F. / Toyooka, S. / Aoe, M. / Okabe, K. / Sano, Y. / Date, H. / Shimizu, N. et al. | 2005
- S372
-
P-961 Buccal mucosa cells as “in vivo” model to evaluate gefitinib response in NSCLC patientsLoprevite, M. / Chiaramondia, M. / Tiseo, M. / Grossi, F. / Dadati, P. / Kunkl, A. / Nizzoli, R. / Franciosi, V. / Rosso, R. / Ardizzoni, A. et al. | 2005
- S375
-
P-972 Pilot study of SGN-15 immunoconjugate with docetaxel as firstline therapy for NSCLC with FDG-PET assessment of responseRoss, H. / Rarick, M. / Rudin, C. / Wahl, R. / Vansant, J. / Leal, J. / Grove, L. / Miller, D. / McDonald, M. et al. | 2005
- S379
-
4 Neoadjuvant chemotherapy and chemoradiotherapy for locally advanced non small cell lung cancer (NSCLC)Gavila, Q. / Almendros, P. / Camps, C. / Ló / pez-Torrecillas, J. / Safont, M. / Blasco, A. / Garde, J. / Juarez, A. / Iranzo, V. et al. | 2005
- S380
-
8 Concurrent chemoradiation therapy with weekly paclitaxel for locally advanced non-small cell lung cancerKim, S. / Shim, B. / Kim, C. / Song, S. / Ahn, M. / Jeong, Y. / Yoo, J. / Kim, H. et al. | 2005
- S381
-
12 Vinorelbine (VNR) plus concurrent thoracic radiation therapy (TR) in non small cell lung cancer (NSCLC) stage IIIPortalone, L. / Brocchieri, P. / Seta, R. / Greco, S. / Lombardi, A. / Luca, F. / Nunziati, F. / Signora, M. et al. | 2005
- S382
-
16 The leukemodi reaction — Prognostic marker of the lung cancerHryb, V. et al. | 2005
- S383
-
20 Synchronous and metachronous lung cancer other than adenocarcinoma in women with breast cancerBerzinec, P. / Detvay, J. et al. | 2005
- S385
-
27 Epidemiology tendencies of lung cancer in Ukraine in 1982–2001yearsVoytko, A. / Ganul, A. / Hulak, L. / Omelchuk, S. / Fedorenko, Z. et al. | 2005
- S387
-
34 Developing a coherent mesothelioma pathway and a dedicatedclinicLowry, E. / Laroche, C. / Old, S. / Magee, L. / Allen, P. / Munday, H. / Ritchie, A. et al. | 2005
- S388
-
37 Gemcitabine (G) as a single drug versus gemcitabine plusvinorelbine (GV) for non-small cell lung cancer (NSCLC) stage IIIB and IVAlberto, S. / Raquel, G. / Alberto, V. et al. | 2005
- S389
-
41 Gefitinib for patients with advanced NSCLC treated on the expanded access programme: A institution experienceCruz, M. / Katz, A. / Simon, S. / Tabacof, J. / Gansl, R. / Smaletz, O. et al. | 2005
- S391
-
50 Mitomycin C, vinblastine and carboplatin: Effective palliativechemotherapy for non-small cell lung cancer (NSCLC)Lester, J. / Hudson, E. / Morgan, C. / Brewster, A. / Court, J. et al. | 2005
- S392
-
53 Concurrent weekly gemcitabine (GEM) plus chest radiotherapy (RT)in the treatment of patients with inoperable Stage III non-small cell lung cancer (NSCLC)Shehata, S. / Abdel Karim, S. / Zaki, T. / Mostafa Kamel, Y. et al. | 2005
- S394
-
62 Anatomical distribution of small cell lung cancer: Effects of lobeand gender on brain metastasis and survivalSahmoun, A. / Case, D. / Santoro, T. / Schwartz, G. et al. | 2005
- v
-
Contents| 2005
-
O-016 Whole genome comparison of SCLC and NSCLC cells identifies novel signature genetic alterationsLockwood, W. / Coe, B. / Garnis, C. / Minna, J. / MacAulay, C. / Lam, S. / Gazdar, A. / Lam, W. et al. | 2005
-
O-027 Recent advances in endoscopic early detection of bronchial lesionsIkeda, N. / Honda, H. / Hayashi, A. / Tsuboi, M. / Usuda, J. / Ohira, T. / Miyajima, K. / Suga, Y. / Hirano, T. / Kato, H. et al. | 2005
-
O-030 A prospective blinded comparison of bronchoscopy versusendobronchial ultrasound versus endoscopic ultrasound fine needle aspiration for the mediastinal staging of lung cancerWallace, M. / Pascual, J. / Raimondo, M. / Woodward, T. / Johnson, M. / Savoy, A. / Noh, K. / Pungpapong, S. / Hardee, J. / Odell, J. et al. | 2005
-
O-043 A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204)Tada, H. / Katoh, H. / Kunitoh, H. / Tsuboi, M. / Asamura, H. / Nagai, K. / Mitsudomi, T. / Koike, T. / Ishizuka, N. / Saijoh, N. et al. | 2005
-
O-063 Do decisions made at lung cancer multi-disciplinary team meetings get carried outGilligan, D. / Goodrum, L. / Magee, L. / Harris, S. et al. | 2005
-
O-093 Meta-analysis of weekly paclitaxel as maintenance therapy foradvanced non-small cell lung cancer (NSCLC) patients following intitial chemotherapyBelani, C. / Barstis, J. / LaRocca, R. / Tester, W. / Gable, P. / Perry, M. / Ramalingam, S. et al. | 2005
-
O-106 A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)Hanna, N. / Bonomi, P. / Lynch, T. / Ansari, R. / Govindan, R. / Janne, P. / Lilenbaum, R. et al. | 2005
-
O-105 Pharmacogenomic study of docetaxel and cisplatin in patients with non-small cell lung cancer (NSCLC) stages IIIb (with malignant pleural effusion) and IVde las Peñ / as, R. / Camps, C. / Lopez-Vivanco, G. / Alonso, G. / Provencio, M. / Gonzalez-Larriba, J. / Artal, A. / Garcia Gomez, R. / Viñ et al. | 2005
-
O-102 Gemcitabine and docetaxel as concomitant or sequential first-linetherapy of advanced non-small cell lung cancer: Updated results of a randomized studyManegold, C. / Thatcher, N. / Kortsik, C. / Koschel, G. / Spengler, W. / Mezger, J. / Mü / ller, A. / Pilz, L. et al. | 2005
-
O-113 Cisplatin plus gemcitabine with or without vinorelbine asneo-adjuvant therapy for radically treatable stage III Non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (Grupo Oncológico del Norte de España)Esteban, E. / Ferná / ndez, Y. / Vieitez, J. / Villanueva, N. / De Sande, J. / Fra, J. / Muñ / iz, I. / Palacio, I. et al. | 2005
-
O-118 The significance of K-ras mutations in the Intergroup JBR.10 Trial on adjuvant chemotherapy in completely resected early stage non-small cell lung cancer (NSCLC) patientsTsao, M. / Zhu, C. / Livingston, R. / Johnson, D. / Gandara, D. / Viallet, J. / Ding, K. / Seymour, L. / Winton, T. / Shepherd, F. et al. | 2005
-
O-125 Gene expression profiling distinguishes large cell lung cancer associated with disparate clinical outcomesBattafarano, R. / Lewis, J. / Ritter, J. / Meyers, B. / Cooper, J. / Patterson, G. / Watson, M. et al. | 2005
-
O-142 Comparison of outcomes for patients with medically inoperablestage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapyFang, C. L. / Komaki, R. / Allen, P. / Guerrero, T. / Mohan, R. / Cox, J. et al. | 2005
-
O-161 Efficacy of antibacterial prophylaxis following myelosuppressive chemotherapy: Results from a randomised, double-blind, placebo-controlled trial of levofloxacin including 220 small cell lung cancer patientsBillingham, L. / Cullen, M. / Steven, N. / Gaunt, C. / Hastings, M. et al. | 2005
-
PD-002 Transcriptional regulation and clinical expression of the stathmin family in lung cancerBennett, E. / Moss, A. / Jacobson, G. / Smith, S. / Mori, N. / Betticher, D. / Blake, N. / Marshall, E. / Heighway, J. / Coulson, J. et al. | 2005
-
PD-025 Prognostic role of Protease-Activated Receptor 1 (PAR-1) and 4(PAR-4) in Stage IB non-small cell lung cancer (NSCLC)Selvaggi, G. / Lausi, P. / Ghio, P. / Novello, S. / Cappia, S. / Papotti, M. / Borasio, P. / Scagliotti, G. et al. | 2005
-
PD-027 Abnormal HLA expression as an immune escape mechanism inlung cancer cell linesSo, T. / Hanagiri, T. / Mizukami, M. / Ichiki, Y. / Sugaya, M. / Takenoyama, M. / Sugio, K. / Yasumoto, K. et al. | 2005
-
PD-037 Early and late toxicity of a phase III study randomizingnon-small cell lung cancer (NSCLC) patients to sequential (S) or concurrent (C) chemoradiotherapy (CRT) EORTC 08972-22973Belderbos, J. / Uitterhoeve, L. / van Zandwijk, N. / Belderbos, H. / Van de Vaart, P. / Giaccone, G. / Legrand, C. / Dussenne, S. / Bartelink, H. / Koning, C. et al. | 2005
-
PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxelBunn, P. / Rosell, R. / Fossella, F. / Perry, M. / Stahel, R. / Barata, F. / Nguyen, B. / Paul, S. / Hanna, N. et al. | 2005
-
PD-097 Macrophage and mast cell invasion of tumour cell islets confers a marked survival benefit in non-small-cell lung cancerO'Byrne, K. / Welsh, T. / Green, R. / Richardson, D. / Waller, D. / Bradding, P. et al. | 2005
-
PD-127 Prognostic implication of microscopic residual tumor at the bronchial margin in non-small cell lung cancerKawaguchi, T. / Watanabe, S. / Suzuki, K. / Asamura, H. / Tsuchiya, R. et al. | 2005
-
PD-131 The impact of stage and cell type on prognosis of pulmonary neuroendocrine tumoursLim, E. / Yap, Y. / DeStavola, B. / Nicholson, A. / Goldstraw, P. et al. | 2005
-
PD-136 Limited resection for peripheral lung cancer smaller than 2 cm —Indication based on GGA area by HRCTNiwa, H. / Takeshi, Y. / Yoshiaki, N. / Masayuki, T. / Tamotsu, S. / Hirohisa, Y. / Takeo, M. et al. | 2005
-
PD-142 ErbB-3 mediates PI3K activity in gefitinib-sensitive non-smallcell lung cancer cell linesEngelman, J. / Janne, P. / Mermel, C. / Pearlberg, J. / Mukohara, T. / Fleet, C. / Cichowski, K. / Johnson, B. / Cantley, L. et al. | 2005
-
P-013 Expression of VEGFs and VEGFRs according to TNMc and TNMq. Reality or fiction?Carrillo Arias, F. / Carrillo de Santa Pau, E. / Pé / rez Rodrí / guez, E. / Toledo Lobo',, M. / Sá / nchez Hernandez, I. / Muñ / oz Molina, G. et al. | 2005
-
P-015 Hypoxic regulation of the cyclooxygenase isozymes in lungcancer mediates tumour cell survival under serum-depleted conditionsCathcart, M. / Pidgeon, G. / O'Byrne, K. et al. | 2005
-
P-026 IL-6 induces apoptosis resistance and VEGF production throughmultiple signaling pathways in non-small cell lung cancerDalwadi, H. / Krysan, K. / Heuze-Vourc'h, N. / Dohadwala, M. / Elashoff, D. / Sharma, S. / Cacalano, N. / Lichtenstein, A. / Dubinett, S. et al. | 2005
-
P-040 Detection of novel genetic alterations in non-small cell lungcarcinomaGarnis, C. / Buys, T. / Lockwood, W. / Vucic, E. / MacAulay, C. / Lam, S. / Lam, W. et al. | 2005
-
P-075 A comprehensive evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers (NSCLC)Le, Q. / Chen, E. / Salim, A. / Cao, H. / Kong, C. / O'Byrne, K. / Mitchell, J. / Donington, J. / Whyte, R. / Giaccia, A. et al. | 2005
-
P-081 Gpcr5a-knockout mouse: A novel model for spontaneous and tobacco carcinogen-enhanced lung adenocarcinomaLotan, R. / Men, T. / Fujimoto, J. / Tao, Q. et al. | 2005
-
P-120 In situ screening for lung cancer markersSung, S. / Kim, S. / Jheon, S. et al. | 2005
-
P-122 Molecular predictor of lymph node metastasis in non-small cell lung cancerTakanami, I. et al. | 2005
-
P-129 MRP1, -3 and -5 protein expression in non-small cell carcinomasand survey after adjuvant chemotherapyVirgile, G. / Manuela, D. / Franç / ois, B. / Chantal, D. / ois, V. / Michel, D. / Pierre, C. / Boris, M. et al. | 2005
-
P-163 Audit of a unique one stop rapid acess lung cancer investigation clinic 4 years onLedson, M. / Hughes, J. / McIver, A. / Walshaw, M. / Smyth, C. et al. | 2005
-
P-165 Probe into clinical significance for cryo-ablation treatingadvanced pulmonary neoplasmsLiu, J. / Kuen, W. / Ying-Chen, L. et al. | 2005
-
P-175 Endoscopic therapy of typical carcinoid tumor of the bronchus-combination of interventional bronchoscopy and operationReinmiedl, J. / Lindner, M. / Stanzel, F. / Morresi-Hauf, A. / Thetter, O. et al. | 2005
-
P-192 Concurrent chemoradiotherapy (CCRT) with paclitaxel followed by paclitaxel and carboplatin consolidation in patients with inoperable stage III non-small cell lung cancer (NSCLC)Bae, S. / Ryoo, H. / Kim, K. / Hyun, D. / Lee, S. / Yei, J. / Bae, J. / Yun, S. / Lee, K. / Hyun, M. et al. | 2005
-
P-271 ITALUNG_CT screening for lung cancer: Preliminary resultsRonchi, M. / Cordopatri, G. / De Francisci, A. / Innocent, F. / Janni, A. / Mascalchi, M. / Masi, A. / Paci, E. / Picozzi, G. / Lopes Pegna, A. et al. | 2005
-
P-283 Prevalence of smoking among secondary schools students inIle Ife, NigeriaAdewole, O. / Folorun, S. O. / Obaseki, D. / Adesina, O. / Erhabor, G. et al. | 2005
-
P-319 Trends in the pattern of care for lung cancer and its correlation with clinical evidences: Experience of 4565 patients in a university-affiliated medical center in Taiwan from 1991 to 2002Chien, C. / Lai, M. et al. | 2005
-
P-332 The incidence, outcomes, and economic burden ofhospitalizations for common medical complications in patients with lung cancer: A population-based studyLu, C. / Jones, J. / Cooksley, C. / Shih, Y. / Elting, L. et al. | 2005
-
P-339 Multidisciplinary versus traditional evaluation in sequentialpatient cohorts with lung cancerRiedel, R. / Wang, X. / McCormack, M. / Toloza, E. / Montana, G. / Schreiber, G. / Kelley, M. et al. | 2005
-
P-342 Diagnostic success rate of single day outpatient evaluation of suspected lung cancervan der Heijden, H. / van der Link, M. / Dekhuijzen, P. et al. | 2005
-
P-344 Patterns of care for lung cancer in New South Wales, Australia:Preliminary resultsVinod, S. / O'Connell, D. / King, D. / Armstrong, B. et al. | 2005
-
P-361 Computed tomography at the subcellular level for early detection of lung cancerFauver, M. / Nelson, A. / Patten, F. / Rahn, R. / Neumann, T. / Meyer, M. / Seibel, E. et al. | 2005
-
P-367 FDG-PET in thymic epithelial tumors (Relationship betweenFDG-uptake and WHO histologic subtype)Hirami, Y. / Nakagawa, K. / Ohde, Y. / Okumura, T. / Kondo, H. / Endo, M. / Yamamoto, N. / Ito, I. / Kameya, T. et al. | 2005
-
P-388 Comparison of Tc-99m MIBI and Tc-99m tetrofosmin scintigraphies in evaluation of benign and malignant pulmonary lesionsTore, G. / Varoglu, E. / Gorguner, M. et al. | 2005
-
P-421 Is prophylactic radiotherapy necessary asprevention of tumour seeding following thoracoscopy in malignant pleural mesothelioma (MPM)?Pinto, C. / Sperandi, F. / Marino, A. / Mutri, V. / Martoni, A. et al. | 2005
-
P-427 Preoperative staging by FDG-PET-CT-scan in patients with resectable malignant pleural mesothelioma (MPM)Sorensen, J. / Jacobsen, A. / Ravn, J. / Berthelsen, A. et al. | 2005
-
P-448 Micronuclei evaluation of reduction in neoadjuvant chemotherapyrelated acute toxicity in Locally Advanced Non Small Cell Lung CancerBahl, A. / Chander, S. / Julka, P. / Rath, G. / Sharma, D. / Kumar, A. / Nair, O. et al. | 2005
-
P-467 Chemotherapy with an every-2-week regimen of gemcitabine (G) and paGitaxel (P) followed by maintenance weekly paGitaxel in elderly patients with stage IIIB or IV in non-small cell lung cancer (NSCLC)Ceribelli, A. / Gamucci, T. / Mansueto, G. / Gareri, R. / Buccilli, A. / Giampaolo, M. / Milella, M. / Trapasso, T. / Pellicciotta, M. / Cognetti, F. et al. | 2005
-
P-482 Activity of topotecan in patients with advanced non-small cell lung cancer pre-treated with platinum and taxanes: Results of the first analysisFerná / ndez, Y. / Esteban, E. / Villanueva, N. / Palacio, I. / Muñ / iz, I. / Jimenez, P. / Luque, M. / Fra, J. et al. | 2005
-
P-483 Gemcitabine and vinorelbine as second-line therapy for non-small-cell lung cancer after prior treatment with taxanes and platinum based regimensGarcí / a Campelo, R. / Alonso Curbera, G. / Gallegos, I. / Quindó / s, M. / Dopico, D. / Reboredo, M. / Antolí / n, S. et al. | 2005
-
P-493 A phase II study of weekly innotecan plus capecitabine for chemo-naive patients with advanced non-small cel lung cancerHan, J. / Lee, D. / Lee, S. / Park, C. / Kim, H. / Lee, H. / Lee, J. et al. | 2005
-
P-492 A multicenter, open-label, phase Ilia trial of erlotinib in patients with advanced non-small cell lung cancerHainsworth, J. / Spigel, D. / O'Neill, V. / Klencke, B. et al. | 2005
-
P-515 Sequential combination chemotherapy for advanced non-small cell lung cancer: Paclitaxel and cisplatin followed by vinorelbine and cisplatinKim, H. / Kwon, J. / Jung, J. / Kim, J. / Song, H. / Lee, K. / Zang, D. / Ahn, J. / Lee, J. / Park, Y. et al. | 2005
-
P-522 A cost minimization analysis of first-line polychemotherapyregimens in the treatment of advanced non-small cell lung cancerLe Lav, K. / Avoinet, S. / Chemali, N. / Vergnenegre, A. / Launois, R. et al. | 2005
-
P-521 Phase II trial evaluating combination, weekly gemcitabineand docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003Langer, C. / Huang, C. / Millenson, M. / Sherman, E. / Seldomridge, J. / Schol, J. / Rogatko, A. / Treat, J. et al. | 2005
-
P-531 Treatment of anemia in elderly patients receiving first-line chemotherapy for advanced lung cancer: Analysis of an unselected populationMansueto, G. / Gareri, R. / Buccilli, A. / Trapasso, T. / Giampaolo, M. / Gamucci, T. et al. | 2005
-
P-535 Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: An implementation studyMeert, A. / Berghmans, T. / Ninane, V. / Sculier, J. et al. | 2005
-
P-556 Results of extended resections for lung cancer with superior vena cava invasionPoliakov, I. / Porhanov, V. / Kononenko, V. / Bodnia, V. / Kovalenko, A. / Skopets, A. / Sitnik, S. et al. | 2005
-
P-589 Gemcitabineldocetaxel (GD) vs gemcitabinelcisplatin (GC) instage IIIB/IV advanced non-small cell lung cancer (NSCLC): Grupo gallego de cancer de pulmon (GGCP)Vá / zquez, S. / Casal, J. / zquez, F. / Amenedo, M. / Fí / rvida, J. / Mel, J. / Huidobro, G. / Lá et al. | 2005
-
P-593 Preliminary results of phase II study of daily paclitaxel andcarboplatin administered concurrently with chest irradiation in stage III unresectable NSCLCWierzchowski, M. / Denisso, T. / Kowalski, D. / Lasota, W. / Zajda, K. / Krzakowski, M. et al. | 2005
-
P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLCBradley, J. / Graham, M. / Swann, S. / Byhardt, R. / Govindan, R. / Fowler, J. / Purdy, J. / Michalski, J. / Gore, E. / Choy, H. et al. | 2005
-
P-673 Classification of histological parietal pleural invasion at adhesion sites with surgical specimens of NSCLC and implications for prognosisSatoh, Y. / Ishikawa, Y. / Inamura, K. / Ninomiya, H. / Inagaki, T. / Matsui, Y. / Hiramatsu, M. / Okumura, S. / Ken Nakagawa, K. / Tsuchiya, E. et al. | 2005
-
P-680 Survivin expression in non-small cell lung carcinomas: Correlation with other apoptosis-related markers, clinicopathologic factors and prognosisUlukus, E. / Kargi, A. / Sis, B. / Lebe, B. / Oztop, x. / Akkoclu, A. / Onen, A. / Sanli, A. et al. | 2005
-
P-728 Palliative radiotherapy in a patient with pulmonary adenoid cystic carcinomaKim, B. et al. | 2005
-
P-732 Is postoperative adjuvant therapy necessary in patients with carcinoid tumors of the lung?Mihai, A. / Shagal, A. / Balogh, J. / Ung, Y. et al. | 2005
-
P-733 Comparison of tumour control probability between the pencilbeam and collapsed cone algorithms for evaluating 3-dimensional plans for the radical treatment of lung cancerMisra, V. / Locks, S. et al. | 2005
-
P-753 Extrapulmonary small cell carcinoma: Our experience over ten yearsDanson, S. / Clamp, A. / Davidson, S. / Wylie, J. / Ashcroft, L. / Wardley, A. / Anderson, H. / Hasleton, P. / Thatcher, N. et al. | 2005
-
P-766 Phase II study of topotecan (T) and paclitaxel (P) as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED-SCLC)Hainsworth, J. / Palmer, M. / Granick, J. / Boston, B. / Bonomi, P. / Althouse, D. / Dharan, B. / Poulin, R. / Wissel, P. et al. | 2005
-
P-802 Metastatic carcinoma in the mediastinum from unknown primary site and its radiotherapeutic palliationAmpil, F. / Mills, G. / Murty, K. R. / Burton, G. et al. | 2005
-
P-887 Local control of lung tumors by percutaneous CT guided cryoablation under local anesthesiaKawamura, M. / Izumi, Y. / Tsukada, N. / Kobayashi, K. / Nakatsuka, S. / Nakano, K. / Kuribayashi, S. et al. | 2005
-
P-893 Surgical treatment of multiple lung cancerKurowski, K. / Andrzej, B. / Witold, R. / Ewa, M. / Artur, G. / Robert, L. / Maja, M. / Jacek, J. et al. | 2005
-
P-902 Bronchopleural fistula after pneumonectomy for lung cancer:Consideration of 450 consecutive casesMossetti, C. / Lausi, P. / Ardissone, F. / Manzone, E. / Selvaggi, G. / Novello, S. / Borasio, P. et al. | 2005